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The thyroid gland consists of two endocrine cell types, the follicular cells that produce the thyroid 
hormones T3 and T4 and the parafollicular C-cells that synthesize calcitonin. It is well-known 
that these cells have different embryonic origin, although details of their specification and 
development during organogenesis are still largely lacking. Tumors arising from the two cell 
types are distinct entities with different treatment and prognosis. 
In paper I mouse thyroid morphogenesis was investigated to provide a detailed map of the 
different stages: specification and placode formation (Embryonic day 8.5-9.5), budding (E10.5), 
migration (E11.5), fusion and bilobation (E13.5), and eventually differentiation (E15.5 and 
onwards). Special interest was paid to patterns of proliferation of progenitor cells and relationship 
to embryonic vessels in the neck. Results of this study formed a platform for further investigation 
in papers II-IV.  
Paper II was designed to investigate the germ layer origin of C-cell precursors by genetic and 
biochemical tracing of cells expressing T-box (Tbx1) and forkhead (Foxa1 and Foxa2) 
transcription factors. This showed that mouse C-cells in all probability arise from the pharyngeal 
endoderm, at difference with the prevailing concept of a neural crest origin originally identified 
for birds. Microarray analysis indicates that Foxa2 is a novel marker of human medullary thyroid 
carcinoma cells. 
Paper III and IV identified the EphA4 receptor as a novel modulator of follicular and C-cell 
proliferation in post-natal life. The effect on the C-cell lineage was obviously cell non-
autonomous as EphA4 was expressed only in the follicular cells. EphA4 was further found to be 
expressed in the embryonic thyroid in a distinct spatiotemporal pattern, although no thyroid 
malformation was detected in EphA4 null embryos presumably due to redundant functions of 
other Eph receptors. The cognate ephrin ligands interacting with EphA4 in the thyroid awaits to 
be identified. 
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ADAM A-Disintegrin-And-Metalloprotease      
AIP Anterior intestinal portal      
cAMP Cyclic AMP      
CIP Caudal intestinal portal     
ClO4- Perchlorate      
E Embryonic day      
EGF Epidermal growth factor      
EGFP Enhanced green fluorescent protein 
EMT Epithelial to mesenchymal transition      
Ephrin Eph family receptor interacting proteins     
FTP Follicular thyroid carcinomas     
IGF-1 Insulin-like growth factor-1      
MAPK Mitogen activated protein kinase      
MTC Medullary thyroid carcinomas     
NCC Neural crest cell     
NIS Na+/I- symporter      
PAA Pharyngeal arch artery      
PKA Protein kinase A      
PTC Papillary thyroid carcinomas  
SH2 SRC-Homology-2     
T3  Tri- and tetraiodotyronine     
T4  Thyroxine     
TBG  Thyroid-binding globulin      
TG  Thyroglobulin      
TPO  Thyroperoxidase      
TRH  Thyrotropin-releasing hormone      
TSH  Thyroid stimulating hormone     
TSHR  Thyroid stimulating hormone receptor     
UB  Ultimobranchial bodies  
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KPVTQFWEVKQP"
This thesis is focused mainly on the embryonic development of the mouse thyroid gland. The 
reason is, much is yet unknown of the molecular mechanisms that determines its formation, from 
the earliest onset of specification of progenitors cells destined to a thyroid cell fate, to the gradual 
process of morphogenesis leading to the final anatomy, histoarchotecture and cellular content of 
two endocrine cell types. Paper I provides a complete map of the morphogenetic stages as the 
mouse thyroid develops, previously lacking in the literature. The findings in paper I form the 
basis of the microscopic evaluation of data in the next papers, in which novel aspects on the 
embryonic origin of thyroid C-cells (paper II), regulation of progenitor cell interactions (paper 
III), and modulation of post-natal thyroid growth (paper IV) by the Eph receptor EphA4 are 
presented. To introduce the work I will here summarize the basic concepts of thyroid structure 
and function, and the developmental process from two originally separated primordia in the 
foregut endoderm. In addition, the genes and molecules of interest will be highlighted. 
Vjg"vj{tqkf"incpf<"igpgtcn""
Cpcvqo{"cpf"egnn"v{rgu"
The butterfly-shaped thyroid gland is located in the anterior neck, on the trachea just inferior to 
the larynx (Figure 1). A median tissue called isthmus connects the two lateral thyroid lobes. The 
functional units of the gland are the follicles in which thyroid hormone is synthesized and stored. 
Each follicle consists of a single layer of epithelial cells (follicular cells or thyrocytes) resting on 
a basement membrane and secluding an inner follicular cavity, the lumen, which serves as the 
actual production place of thyroid hormones and storage after their synthesis. Calcitonin 
producing C-cells located between the follicles in a so-called parafollicular position are the 
second endocrine cell type of the thyroid. Although C-cells are scattered throughout the gland, 
they are mostly distributed medially in the centre of each lobe reminiscent of the embryonic 
development (Figure 1). 
Jqtoqpg"u{pvjguku"
Thyroid hormones are key regulators of metabolism and development in all vertebrates and they 
apply their effects on almost every cell in the body. Thyroid hormones have multiple actions 
which include: somatic growth, homeostasis of the cardiovascular system, development of the 
nervous system and regulation of the metabolic rate (Boelaert and Franklyn 2005). Iodine is an 
essential component of thyroid hormone. From an evolutionary point of view, when a variety of 
species moved from an iodine-rich environment for example the sea to the relatively iodine-
deficient environment, it is thought that this change forced the development of both the follicular 
structure and novel molecular mechanisms that are more efficient in capturing inorganic iodide (I-
) required for the formation of thyroid hormones (Venturi, et al. 2000). The cells thus actively 
take up iodide from the circulation. Iodide is transported into the thyrocytes by the sodium iodide 
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(Na+/I-) symporter (NIS), which is expressed only at the basolateral cell surface and functionally 
coupled to the sodium ion gradient generated by Na+/K+-ATPase (Dai, et al. 1996). The 
negatively charged iodide therefore enters the follicular lumen against its concentration gradient 
(De La Vieja, et al. 2000). Iodine accumulated in the follicle lumen is covalently bound to a large 
glycoprotein, thyroglobulin (TG), that constitutes the prohormone in which the thyroid hormones 
are integrated. This occurs by iodination and coupling of tyrosyl residues in TG after it is secreted 
by the thyrocytes into the follicle lumen. Hormongenesis normally takes place 
 
Figure1 .  Structure of the thyroid gland and overview of thyroid hormone synthesis. Note that C-cells (Cc, 
grey) can either have a parafollicular position or be integrated in the follicular wall,  but always outside the 
epithelial layer of thyrocytes facing the foll icle lumen (L).  See text in thesis for further explanation of 
abbrivations.  AC, adenylate cyclase; ATP, adenosine triphosphate;  c, capillary; cAMP, cyclic adenosine 
monophosphate; Cc, C-cell; DH, dehalogenase. 
extracellularly at the apical cell surface. Iodine becomes oxidised once it enters the follicular 
lumen in a process that requires hydrogen peroxide (H2O2) produced by the thyrocytes 
themselves and thyroperoxidase (TPO) that catalyzes the reaction. Effective means to inhibit 
thyroid hormone synthesis is withdrawal of iodide by competitive inhibition of NIS-mediated 
iodide uptake by perchlorate (ClO4-), and prevention of iodination by antithyroid drugs (e.g. 
methimazole) that blocks TPO activity. Both compounds may be used clinically for treatment of 
hyperthyroidism and experimentally in investigations of thyroid functions. Secretion of thyroid 
11
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hormones into the bloodstream begins with endocytosis of iodinated TG from the follicle lumen, 
followed by protolytic cleavage of the prohormone by lysosomal enzymes which result in the 
release of T3 and T4 (tri- and tetraiodotyronine, the latter also known as thyroxine) for transport 
out of the cell and into the capillaries. The majority of circulating hormones is bound to plasma 
proteins (thyroid-binding globulin (TBG), transthyretin and albumin); only the free pool of T4 
and T3 is metabolically active in target cells (Figure 1). 
Tgiwncvkqp"qh"hwpevkqp"
The synthesis and release of thyroid hormone into the circulation is regulated by thyroid 
stimulating hormone (TSH) from the pituitary gland by a negative feedback mechanism 
(Shupnik, et al. 1989). The release of TSH from cells in the anterior pituitary is modulated by 
thyrotropin-releasing hormone (TRH) produced by the hypothalamus. TSH production is 
suppressed when T4 levels are high, leading to decreased activity of the thyroid gland. Contrary 
to this, TSH is elevated in response to reduced T4, which stimulates the thyroid to increase both 
the TG production and the iodide uptake and also to accelerate thyroid hormone synthesis and 
release. Disturbances of hormone supply at any level eventually lead to impaired thyroid 
function, which can be diagnosed by monitoring the circulating levels of TSH, T3 and T4. At the 
cellular level TSH exerts its effects by activation of the TSH receptor (TSHR). Several 
intracellular signalling pathways act downstream of TSHR, the most important being generation 
of cyclic AMP (cAMP) that triggers or enhances the activity of protein kinase A (PKA).  
Tgiwncvkqp"qh"itqyvj"
The thyroid size in adults is not much changed during the lifetime unless exposed to goitrogenic 
stimulation. However, on demand thyroid growth and enlargement can be outstanding, e.g. in 
severe iodine deficiency. In this situation it is the elevated TSH concentration in blood that 
triggers the thyroid cell to proliferate. Once a matter of debate, it is now established that TSH is a 
mitogen that stimulates thyroid cell cycle progression and mitosis through the TSHR-cAMP-PKA 
pathway (Roger, et al.). In addition, thyrocytes are susceptible to various peptide growth factors, 
e.g. epidermal growth factor (EGF) and insulin-like growth factor-1 (IGF-1), which modulate 
thyroid growth both normally and in pathological conditions. 
Growth regulation of the fetal thyroid is very much an unexplored field. Of interest, as evidenced 
by the mild structural phenotype in TSHR null mice (Postiglione, et al. 2002), TSH has no role in 
the expansion of the follicular cell lineage during thyroid organogenesis in the embryo. Several 
embryonically active factors that if genetically deleted lead to agenesis or hypoplasia of the gland 
have been identified (some of these will be mentioned and discussed in coming paragraphs). 
However, in most cases this appears to be secondary to defective morphogenetic signals. 
Mitogens required for embryonic thyroid growth are yet to be discovered. 
Papers I and III of the thesis are in part focused on embryonic thyroid growth and the expansion 
of thyroid progenitors to their differentiated descendants. Post-natal growth of the thyroid and 
growth responsiveness in adult gland is investigated in papers III and IV. 
12
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Vj{tqkf"fgxgnqrogpv"
Rtqigpkvqtu"qh"fkhhgtgpv"qtkikp"
The thyroid gland is in mammals formed by fusion of one midline and two lateral anlagen, all 
developed from the anterior foregut. This developmental process follows a sequence of 
morphogenetic steps that are similar in humans and mice (Figure 2). The progenitor origins of the 
two endocrine cell types populating the thyroid are essentially different and will be focused on in 
detail in several of the papers included in the thesis. A short summary of the main background 
information is therefore warranted.  
The follicular cells 
Thyroid specification giving rise to progenitors of the follicular cell lineage takes place in the 
anterior endoderm. The cells assemble to form the midline thyroid primordium, which is first 
observed as a thickening of the foregut endoderm at the base of the prospective tongue. This 
thickening is termed the thyroid placode and can be distinguished molecularly from the rest of the 
endoderm by the co-expression of four transcription factors: Nkx2.1, Foxe1, Hhex and Pax8 
(Civitareale, et al. 1989; Guazzi, et al. 1990) (Plachov, et al. 1990) (Zannini et al. 1997) (Bedford, 
et al. 1993; Crompton, et al. 1992) (Figure 3). These transcription factors also have central 
functions in other embryonic tissues, but it is only in the endoderm cells committed to a thyroid 
fate the combination of all four can be found. Several of these transcription factors not only 
regulate thyroid development but also thyroid differentiation, e.g. the expression of NIS and TG 
in both embryonic and adult thyrocytes. There are no controversies regarding the endoderm 
origin of the follicular cells. However, it is still not known whether the placode is the actual site 
of specification or whether progenitors not yet expressing the characteristic set of biomarkers 
arise in other parts of the endoderm and migrate into the placode by lateral movements. 
The C-cells 
The ultimobranchial bodies (UB) serve as vehicles for the transport of C-cells into the thyroid 
prior to the fusion with the midline primodium. Even though the mechanisms by which C-cells 
enter the embryonic thyroid have been known for almost half a century, the embryonic origin of 
the C-cell precursor is still being discussed. In 1974, a neural crest origin of avian C-cells became 
evident in the classical quail-chick grafting experiments, in which the cranial neural crest division 
that comes to populate the pharyngeal apparatus was found to differentiate into C-cells in the 
ultimobranchial gland (Le Douarin, et al. 1974; Polak, et al. 1974). Although not formally 
proven, it is generally assumed that mammalian C-cells are also descendants of neural crest 
(Adams and Bronner-Fraser 2009). However, this concept of C-cell origin was recently 
challenged by results achieved from fate mapping experiments in mice. Kameda et al. used Wnt1-
Cre/Rosa26R double heterozygous mutant embryos to map neural crest-derived cells as they 
migrate into the pharyngeal arches, but failed to identify any Wnt1 expressing cells in the 
ultimobranchial bodies or in the thyroid co-localizing with the C-cells. From this, the authors 
proposed that C-cells might originate from endoderm rather than the neuroectoderm (Kameda, et 
al. 2007).  
13
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The embryonic origin of various cell types has been significantly modified in recent years due to 
the adoption of new techniques. Of particular interest, this notion accounts for gut endocrine cells 
(Thompson, et al. 1990). As early as 1924 Danisch  suggested a neural origin for enteroendocrine 
cells that were believed to migrate from the solar plexus into the intestinal epithelium (Thompson 
et al. 1990). In the late 1960´s Pearse introduced the APUD (amino precursor uptake and 
decarboxylation) model, in which both C-cells and neuroendocrine cells of the gut together with a 
great number of other cell types were all considered as neural crest derivatives (Pearse 1968, 
1977). Some years later in 1990, Thompson et al. showed that gut endocrine cells share a 
common stem cell with other epithelial cell lineages and therefore are specified within the 
endoderm  (Thompson et al. 1990). 
The embryonic origin of an organ-specific cell is of central interest when it comes to tumours, 
because certain embryonic features related to growth and migration traits established during 
development may be recapitulated in malignantly transformed cells arising from it (Dubeau 
2008). In a broader sense, the embryonic origin is also recognized in thyroid cancer. Malignant 
thyroid tumours are divided in two groups reflected by the ancestor cell: follicular and papillary 
thyroid carcinomas (FTP, PTC) from the follicular epithelium and medullary thyroid carcinomas 
(MTC) from the C-cells. MTC belongs to the neuroendocrine family of tumours mainly 
designated by the expression of neuronal biomarkers but also the assumed embryonic origin of 
human C-cells.  Whether embryonic programmes putatively involving oncogenic effects of 
developmental growth signals are reactivated in thyroid carcinoma cells is, however, unknown.    
Oqtrjqigpgvke"uvcigu""
A central theme in this thesis is thyroid morphogenesis. In particular paper I, where we tried to 
pinpoint the key morphogenetic events in mouse, as the mechanisms to these sequence of events 
are largely unknown. To be able to discover organ malformation and phenotypic changes in for 
example mouse models of disease, it is important to have a detailed overview of normal 
development. It is therefore appropriate to shortly summarize the various stages of the 
developmental process leading to the final anatomy and composition of the gland (Figure 2). 
As already introduced, the thyroid consists of cells from fused anlagen, one median and two 
laterals, which emerge from different regions of the pharyngeal endoderm. In the following 
overview, the two anlagen will be described separately until they fuse. The main steps that can be 
identified and addressed are; specification and placode formation, budding and detachment of 
bud, downward migration of midline anlage, symmetric bilobation, fusion of primordia and 
eventually lobe growth and differentiation of progenitors. Mouse and human thyroid 
developments follow essentially the same pattern although timing is different (Trueba, et al. 
2005); estimated embryonic ages for each developmental stage in mice and humans are 
highlighted. However, most details are derived from mouse studies (Figure 2).  
As mentioned, the cells forming the thyroid placode (Mouse: E8.5-9.5, Human: 4th week) in the 
anterior foregut endoderm co-express Nkx2.1, Foxe1, Pax8 and Hhex. These transcription factors 
are all obligatory for normal thyroid development. The first noticeable specified thyroid  
14
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Figure 2.  Overview of thyroid development. Tr, trachea; UB, ultimobranchial bodies; Ph.endo, pharygeal 
endoderm. See text in thesis for further explanation. 
progenitors can be recognized as a subpopulation of cells that become crowded, resulting in the 
thickening of the ventral wall of the primitive pharynx, in the midline at the level of the first and 
second pharyngeal arches. The thyroid placode gradually becomes pseudostratified before the 
actual budding process takes place.   
15
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The ultimobranchial bodies (UB), which constitute the lateral thyroid anlage, can be recognized 
in the mouse embryo approximately one day later than the thyroid placode. The paired UB 
originates from the fourth pharyngeal pouches. However, a morphologically disceranble placode 
of gathered UB progenitors cannot be distinguished before budding takes place. The thymus and 
parathyroid glands develop from the third pouch by a similar mechanism. All three organs that 
bud from these locations require the transcriptional activity of  Tbx1, expressed in the pharyngeal 
endoderm.  
The increase in number of thyroid progenitor cells enlarges the placode which forms a cup 
shaped evagination or diverticulum of the midline pharyngeal floor (Mouse: E9.5-11.5, Human: 
4-5th week). Budding occurs caudally into the ventral mesenchyme, and as the bud grows the 
connection to the pharyngeal endoderm, the thyroglossal duct, becomes thinner and eventually 
disappears. The mechanisms of thyroid budding and regression of the thyroglossal duct have not 
been elucidated. In other organs budding from the endoderm i.e. the liver, lung and pancreas the 
outgrowing bud is formed due to proliferation of progenitor cells (Zaret and Grompe 2008). 
The budding UB is formed by a single layer of tall epithelial cells surrounding a lumen that 
initially is continuous with the pharyngeal cavity. The lumen is retained for a considerable time 
after budding is completed. Similar to the midline primordium, the budding mechanism is not 
known.  
Around day E11.5-12.5 (Human: 5-7th week), the developing thyroid has moved in a caudal 
direction away from the endoderm, but it still holds the midline position. There are different 
theories about embryonic thyroid migration, if it is an active or passive process or both.  How this 
migration of the thyroid progenitors is regulated will be discussed further in paper I. The 
detached UB now move freely from their site of origin in the pharyngeal endoderm approaching 
the expanding midline thyroid.  
One day later in the mouse embryo (Mouse: E13-13.5, Human: 7-8th week), the two thyroid 
anlagen forming three migrating primordial tissues starts to fuse. The UB are enclosed in the 
parenchyma of the midline thyroid so that both progenitor tissues contribute to the formation of 
the prospective thyroid lobes. By E15.5, the first confirmation of follicular organization appears 
with small follicles distributed within the gland. At this stage, calcitonin producing C-cells 
derived from the UB can also be distinguished in the follicles (Mouse: E13.5-17.5, Human: 10-
12th week). 
Vj{tqkf"vtcpuetkrvkqp"hcevqtu"
As already mentioned, the thyroid progenitors of the midline primordium express four 
transcription factors: Nkx2.1, Pax8, Foxe1 and Hhex (Figure 3). As these transcription factors are 
absolutely indispensable in normal thyroid development, their expression pattern and 
developmental roles will be summarized shortly.  
Nkx2.1 
Nkx2.1 (formerly known as TTF-1, for thyroid transcription factor 1) is a homeodomain-
containing transcription factor that first was identified because of its binding to specific DNA 
16
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sequences present in the TG and TPO promoter (Civitareale et al. 1989; Guazzi et al. 1990). 
During embryogenesis, Nkx2.1 is expressed in the midline thyroid anlage, the trachea, lungs, 
pituitary and the forebrain (Lazzaro, et al. 1991). Furthermore, Nkx2.1 transcripts have been 
described to be present in C-cells (Suzuki, et al. 1998) and in the ultimobranchial bodies (UB) 
(Mansouri, et al. 1998). However, the pharyngeal endoderm adjacent to the thyroid placode and 
developing UB does not express Nkx2.1, thus indicating its specificity as biomarker of thyroid 
progenitor cells. 
Mice deficient of Nkx2.1 are stillborn, due to respiratory failure (Kimura, et al. 1996). The 
thyroid bud is hypoplastic and regresses completely by E12-E13 (Kimura, et al. 1999; Parlato, et 
al. 2004). In these animals, the early thyroid development is not disturbed. As the formation of 
the thyroid placode and subsequent pseudostratification of the early bud in the pharyngeal 
endoderm take place apparently normally (Parlato et al. 2004). Thus, Nkx2.1 seems to be 
important in completing the budding process. Later on, thyroid rudiment regresses presumably 
through apoptosis of progenitor cells. In addition, the UB are correctly shaped at first but 
degenerate after budding (Kusakabe, et al. 2006). As a result, both UB and C-cells are absent in 
Nkx2.1 knockout mice.  The experimental results indicate that Nkx2.1 is expendable for the initial 
specification of both thyroid primordia, but is required for the survival of all known cell types 
involved in thyroid development. 
Haploinsufficiency in humans give rise to a syndrome characterised by thyroid hypoplasia, 
neurological disturbance and pulmonary disease (Krude, et al. 2002; Pohlenz, et al. 2002). 
Screening of patients with CH indicate that only a very few cases of thyroid dysgenesis are due to 
mutations in Nkx2.1. In humans, homozygote Nkx2.1 mutations have not been found and are 
therefore probable not compatible with survival of the foetus. Mice heterozygous for Nkx2.1 
exhibit mild hypothyroidism with elevated serum levels of TSH. 
Pax8  
Pax8 (paired box gene 8) is a member of a family of transcriptions factors characterised by the 
present of a 128-amino acid DNA binding domain (paired domain) (Plachov et al. 1990). It is 
involved in thyroid development and gene expression after follicular differentiation. Comparable 
to Nkx2.1, Pax8 recognizes specific sequences in the promoter region regulating TPO and TG 
Pax8 is detected in the developing thyroid from E8.5 onwards. Moreover, expression of Pax8 is 
maintained in the thyroid follicular cells during all stages of development and in adulthood. 
Remarkably, Pax8 directly interacts with Nkx2.1 in differentiated thyroid follicular cells and is 
the only one of the four transcriptions factors that has an endoderm expression restricted to the 
median thyroid primodium (Figure 3). 
Mice lacking the Pax8 gene are born at an expected Mendelian frequency, but with low body 
weight already at birth. Growth retardation becomes more and more prominent and only 20% of 
the pups survive until three weeks of age (Friedrichsen, et al. 2003; Mansouri et al. 1998). These 
animals suffer from severe congenital hypothyroidism (CH) as indicated by undetectable T3 and 
T4 (Friedrichsen et al. 2003) and high TSH level (Friedrichsen, et al. 2004). Hypothyroidism is 
an obvious cause of death since Pax8 mutants can be rescued by supplementary thyroxin (T4) 
treatment (Friedrichsen et al. 2004). In Pax8 null mice embryos the midline thyroid anlage is 
properly specified, and the bud forms, detaches and migrates normally. However, just like in the 
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Nkx2.1 knockouts, the thyroid regresses totally soon afterwards (Mansouri et al. 1998). In 
contrast, the UB develop normally and C-cells can differentiate in these animals. In fact, newborn 
Pax8 null mice have an undeveloped gland that more or less completely consists of C-cells. Thus 
indicating that the gland is devoid of thyroid follicular cells, consisting only of cells derived from 
UB. 
In humans haploinsufficiency of the Pax8 gene causes CH, with variable thyroid phenotypes, 
either hypoplasia or ectopic thyroid tissue (Macchia, et al. 1998). 
Foxe1 
The forkhead/winged-helix domain transcription factor Foxe1 (Zannini, et al. 1997) (formerly 
called TTF-2 for thyroid transcription factor-2), is detected in the entire foregut endoderm at 
E8.5. Expression of Foxe1 in the thyroid cell precursors is continued during development and 
persists in adult thyroid follicular cells. Foxe1 deficient mice are born at an expected ratio but die 
a few days after birth, almost certainly due failure to thrive because of the severe cleft palate (De 
Felice, et al. 1998). The thyroid gland cannot be detected in its normal position and hormone 
analysis reveals severe CH. In early thyroid morphogenesis, the thyroid develops normally in the 
Foxe1 knockout animals. The placode is formed and a rudimentary bud is shaped. However, at 
E9.5, thyroid precursor cells either retains a position at the base of the prospective tongue, present 
also in late development (E15.5), or in some cases no thyroid gland can be found at all. These 
results have proposed that Foxe1 is necessary during thyroid development in order to govern a 
normal migration of the mouse thyroid primodium, and supporting progenitor cell survival (De 
Felice et al. 1998). Even though the thyroid have changed position and size the progenitors are 
able to differentiate and start to synthesise TG (De Felice et al. 1998). 
In humans, homozygote Foxe1 mutations, give rise to a rare disease characteristic of cleft palate, 
athyreosis and spiky hair (Clifton-Bligh, et al. 1998). 
Hhex 
The Hhex was first identified in hematopoietic cells and was therefore named Hhex 
(hematopoietically expressed homeobox) (Bedford et al. 1993; Crompton et al. 1992). Hhex is 
extensively expressed in the endoderm and later becomes concentrated in organ primordial 
derived from the foregut, such as the thyroid, liver, lungs, thymus and pancreas (Bogue, et al. 
2000; Thomas, et al. 1998). Hhex is an early marker for thyroid morphogenesis. At E9.5 the 
thyroid primodium is absent or hypoplastic (Martinez Barbera, et al. 2000), only a few non-
migrating cells compose the thyroid primodium. Before the regression, the remaining thyroid 
progenitors do not express Nkx2.1, Foxe1 or Pax8. Hhex deficient mice die at E15.5 due to 
multiple malformations, most notably, the liver is absent and a major reduction of forebrain tissue 
is observed. 
No Hhex mutations have been found in humans. The severity of the phenotype found in mice 
suggests that this is not compatible with life. 
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F{uigpguku"
Defective development of the thyroid gland is the most frequent cause of congenital 
hypothyroidism (CH), a condition that affects infants from birth (congenital) and results from a 
partial or complete loss of thyroid function (hypothyroidism). CH is the most common endocrine 
disorder in newborns, with an incidence of about 1 of 3500 newborns (Toublanc 1992). Dwarfism 
and mental retardation, also known as cretinism, are the predominate features of children with 
untreated CH. Early detection of CH with neonatal screening programs together with substitution  
 
Figure 3. Expression pattern of Nkx2.1, Foxe1, Pax8 and Hhex in the pharyngeal endoderm. Nkx2.1 and 
Pax8 are restricted to thyroid progenitors forming the thyroid placode. Foxe1 and Hhex are ubiquitously 
expressed in foregut endoderm cells. Black marks protein expression in the pharyngeal endoderm. 
therapy using thyroxine is therefore mandatory to prevent irreversible brain damage. Thanks to 
early treatment, CH patients will reach full intellectual capacity as indicated in comparison 
studies with healthy control siblings (1981; Fisher and Klein 1981). In about 85 percent of cases 
with CH the thyroid gland is either absent (thyroid agenesis or athyreosis), abnormally located 
(thyroid ectopy), or severely reduced in size (thyroid hypoplasia). All of these conditions are 
collectively named thyroid dysgenesis (Fisher and Klein 1981) and are in most instances sporadic 
and of unknown pathogenesis; mutations in known developmental genes have been described for 
only a handful of CH patients in which the cause is dysgenesis (Heinrichs, et al. 2000; Van Vliet 
1999). In the remaining cases, a normal-sized or enlarged thyroid gland (goiter) is present but the 
production of thyroid hormones is decreased or absent. The cause can be traced to a defect in one 
of the many genes implicated in thyroid hormone synthesis (i.e. TG, TPO, NIS, pendrin, Thox2, 
iodotyrosine dehalogenase). Dyshormonogenesis are transmitted as classical autosomal recessive 
mendelian traits. 
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Hqtgiwv"fgxgnqrogpv""
Some issues investigated and discussed in this thesis concern the endoderm and in particular its 
anterior part forming the foregut. Key morphogenetic events and molecules implicated in 
endoderm development will therefore be highlighted in the following paragraphs. The 
presentation is by no means complete, thus for comprehensive reviews on this topic, see 
following articles; (Kaestner 2005; van den Brink 2007; Zaret and Grompe 2008). 
During gastrulation of vertebrate embryos, the epiblast will form three germ layers; endoderm, 
mesoderm and ectoderm. The endoderm later differentiates into the epithelial lining of the 
pharynx, lungs, oesophagus, stomach and intestines. The endoderm also contributes significantly 
to the formation of glandular organs like the thyroid, parathyroid, thymus, pancreas and liver. The 
mesoderm will form the cardiovascular system, kidneys, muscle, blood and bone. The ectoderm 
gives rise to the epithelium of the skin (epidermis) and the central nervous system.  
Vjg"gpfqfgto"cpf"iwv"vwdg"
In the mouse embryo gastrulation starts at E6.25 with the ingression of epiblast cells through the 
primitive streak. In this process the epiblast cells undergo epithelial to mesenchymal transition 
(EMT), a phenotypic change that supports cell migration. From earlier fate mapping studies, it is 
proposed that the endodermal sheet can be subdivided in four distinct regions (Lawson, et al. 
1986; Lawson and Pedersen 1987). Region I, the anterior-most region, forms the ventral foregut 
that later on during development differentiate into the lungs, part of the stomach, the ventral 
primordium of the pancreas and the liver.  
 
Figure 4. Folding of the embryo. A: The ventral side is located towards the outside of the embryo at E8. B: 
After a series of complex turning movements (for more details see the thesis text), the ventral side ends up 
at the inside of the embryo forming the anterior intestinal portal (AIP) and caudal intestinal portal (CIP).  
Arrow pointing at the presumptive location of the thyroid anlage. Adapted from Van den Brink 2007. 
The dorsal foregut is formed from region II and will form the oesophagus, part of the stomach, 
and the dorsal pancreas and duodenum. Finally, region III and IV become the small and large 
intestine, respectively. Even though it has not been addressed experimentally, thyroid 
progenitors are most likely to be specified within region I.  
Th 
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The gut is formed by a complex series of folding events that convert the flat endoderm sheet into 
a tubular structure (Grapin-Botton and Melton 2000). The folding begins in the anterior part of 
the embryo by a ventral folding of the anterior-most endoderm. This fold generates a pocket, the 
so-called anterior intestinal portal (AIP). A similar fold, the caudal intestinal portal (CIP), arises 
later at the posterior end of the embryo and moves anteriorly. The two folds meet at the stalk of 
the yolk sac were the forming gut closes ventrally. Concurrently, the lateral endoderm folds 
ventrally, by which closure of the gut tube is completed. The folding of the endoderm sheet 
alters the anterior-posterior positioning of cells as compared to the site they where 
originally incorporated in the definitive endoderm (Grapin-Botton and Melton 2000). 
Progenitors of budding organs may thus move considerable distances before they reach the 
spot where organogenesis starts (Zaret and Grompe 2008).  
  
Figure 5. Coronal section through the pharyngeal arch region at E11 in mouse. Numbers specify the 
pharyngeal archers and pouches. Thyroid primodium (tp) is located between arches I (1) and II (2). The 
ultimobranchial bodies (UB) are formed from the 4th pharyngeal pouches.  The right figure shows a 
magnification of two pharyngeal arches. Each arch has an ectodermal layer (ec) on the outside and an 
endodermal layer (en) on the inner side. Internally, the arches have a concentric structure throw which a 
centrally located pharyngeal arch artery (a) passes, surrounded by neural crest cells (NCC) and mesoderm 
(m). Adapted from Manly and Capecchi, 1995. 
Rjct{pigcn"ctejgu"cpf"rqwejgu "
The pharyngeal apparatus is the most cranial part of the newly formed foregut. It consists of a 
series of paired bulges on the lateral surface of the embryonic head known as the pharyngeal 
arches. The arches are separated by clefts on the outside (skin surface) and pouches on inside 
facing the pharyngeal cavity. As already pointed out, the pharyngeal arches and pouches are 
transient embryonic structures that give rise to many of the tissues and organs in the head and 
neck region of vertebrates, notably craniofacial bone and muscles, the pharynx, and the thyroid, 
parathyroid and thymus. The arches and pouches are named by roman numerals (I-VI) as they 
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develop in a cranial to caudal direction, the most cranially positioned are numbered I. Each arch 
consists of cells from all three germ layers, ectoderm, mesoderm and endoderm. The external 
arch surface is covered by ectoderm, the internal by endoderm (Figure 5). The centre of each arch 
is traversed by a vessel, the so-called pharyngeal arch artery (PAA), which connects the heart to 
the dorsal aorta. Each artery is surrounded by mesoderm and neural crest cells (Figure 5), the 
latter of which have migrated into the arches from the rhombomeres (Krull 2001).  
The neural crest cells of the upper arches will later differentiate into cranio-facial connective 
tissue and skeleton (Jiang, et al. 2000; Noden 1983). Crest cells of the lower arches are believed 
to contribute to the development of pharyngeal pouch derivatives. As thyroid relationships to 
embryonic vessels in the neck were investigated in paper I, the development of this vasculature 
need to be shortly described. The PAA develop bilaterally and sequentially as the pharynx 
segments and allows blood to flow from the heart tube to the dorsal aorta (DeRuiter, et al. 1993). 
The arteries form in a cranial to caudal direction accompanying the temporal development of the 
corresponding arches. Hence, the arch arteries are numbered I, II, III, IV, and VI (artery number 
V either does not exist or forms incompletely without any involvement in adult structures). In 
mouse embryos, at E10.5 both PAA number I and II have regressed into capillary beds whereas 
arteries number III, IV and VI persist in their respective arches. Starting from E11.5, the caudal 
PAAs undergo extensive asymmetrical remodelling and eventually convert into the definitive 
great vessels arising from the aortic arch (Srivastava and Olson 2000). 
Tqng"qh"Uqpke"Jgfigjqi"*Shh+"igpg"kp"rjct{pigcn"crrctcvwu"
Hedgehog proteins are major morphogens in embryonic development. Three mammalian 
hedgehog genes, Sonic hedgehog (Shh), Indian hedgehog (Ihh), and Desert hedgehog (Dhh) have 
been identified, each of them implicated in organ morphogenesis in the gut (Chiang, et al. 1996; 
Hebrok, et al. 1998; McMahon, et al. 2003; van den Brink 2007). Shh is of particular interest 
since it is expressed in the foregut endoderm and was recently shown to regulate mouse thyroid 
development (Fagman, et al. 2004). In the mouse embryo Shh expression is first detected at E7.25 
in the midline mesoderm. However, already at E7.75 Shh is expressed in the node, the notochord, 
and the definitive endoderm in which it is initiated in the anterior endoderm and thereafter is 
expanding into the posterior endoderm (Echelard, et al. 1993). Of interest, Shh is excluded from 
the thyroid and pancreatic anlagen indicating a non-cell autonomous mode of action in the 
development of these tissues (Apelqvist, et al. 1997; Fagman et al. 2004). In contrast, Shh is 
ubiquitously expressed in the pharyngeal arches and pouches, both in the ectoderm and the 
endoderm. Consequently, Shh null embryos develops a severely malformed pharyngeal apparatus  
(Chiang et al. 1996). 
Shh acts as a key regulators of embryogenesis and has been found to be crucial to foregut 
development (Litingtung, et al. 1998). Specifically, separation of the oesophagus and trachea and 
also branching of the distal airways fails in Shh deficient mice (Litingtung et al. 1998) Shh binds 
to the receptor Patched (Ptc) on target cells (Marigo and Tabin 1996) eventually leading to 
relieved inhibition of the interacting co-receptor Smoothened (Smo) (Murone, et al. 1999). Shh 
downstream signalling involves both Foxa2 and Tbx1 signalling. Shh is not investigated in this 
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thesis work, but as Foxa2 and Tbx1 expression are studied in paper II the signalling pathway will 
be considered. 
Tqng"qh"vjg"V/dqz"vtcpuetkrvkqp"hcevqt"*Tbx1+"kp"rjct{pigcn"crrctcvwu  
Tbx1 belongs to the T-box family of transcription factors that is characterized by homology in a 
DNA-binding domain known as the T-box (Bollag, 1994; Chieffo et al., 1997). The members are 
expressed in a tissue specific fashion during embryogenesis and adulthood (Papaioannou and 
Silver, 1998; Smith, 1999). Tbx1 is required for the development of the pharyngeal apparatus and 
therefore of potential interest in thyroid morphogenesis. Indeed, in our lab, we recently 
documented a developmental defect in thyroid in mice embryos deficient for Tbx1 (Fagman et al. 
2004). Tbx1 expression is restricted to the pharyngeal endoderm and the mesodermal core of the 
pharyngeal arches; no Tbx1 expression can be found in the neural crest-derived mesenchyme of 
the pharyngeal arches (Garg, et al. 2001). It is also not expressed in the midline thyroid 
primordium (Fagman et al. 2004).  
For almost 10 years ago, Tbx1 was discovered as the gene responsible for the phenotype observed 
in patients with DiGeorge syndrome. Typical features of DiGeorge syndrome also recognized in 
Tbx1 deficient mice are cardiovascular malformations in the head and neck region. Hence, in 
Tbx1-/- embryos the first pharyngeal arch is abnormally patterned, the second is hypoplastic, and 
the third, fourth and sixth are not possible to distinguish (Baldini 2005). In addition, thymus and 
parathyroids are rudimentary or lacking (Liao, et al. 2004), making this a mouse model of the 
complete spectrum of anomalies characterizing DiGeorge syndrome. The thyroid phenotype can 
be separated in two defects. Firstly, lack of C-cells that probably depends on the absence of 
ultimobranchial bodies. Secondly, thyroid hypoplasia that may be related to impaired vessel 
interactions of the budding thyroid (Fagman et al. 2004). The basis of the latter hypothesis is 
presented in paper I. Moreover, Tbx1 is used for tracing descendants of the pharyngeal endoderm 
into the developing thyroid (paper II). 
Tqng"qh"hqtmjgcf"dqz"*Fox+"igpgu"
The forkhead box A (Foxa) gene family was first named hepatocyte nuclear factor 3 on the basis 
of its regulatory role on liver-specific gene expression. The family has three members: Foxa1, 
Foxa2 and Foxa3 (previously termed HNF3-?, -? and –?). The Foxa2 gene is the first to be 
activated during mouse embryogenesis and its expression is detected in the anterior primitive 
streak and the node at E6.5 (Friedman and Kaestner 2006). Both Foxa1 and Foxa2 are expressed 
very early in the definitive endoderm and this persists in endoderm-derived organs such as lungs, 
liver, stomach and pancreas in which tissue specific genes are regulated (Bohinski, et al. 1994; 
Cereghini 1996; Wu, et al. 1997). Both genes are also expressed in adult organs, although the 
functions are probably different than during development. The effects of Foxa1 and Foxa2 are 
often redundant, but exceptions exist. For example, in the early embryo Foxa2 is expressed in the 
node, the notochord and floorplate whereas Foxa1 is detected only in the notochord and 
floorplate (Monaghan, et al. 1993; Sasaki and Hogan 1993). 
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The significance of Foxa2 in early embryogenesis has been shown in embryos deficient for 
Foxa2. Embryos die by E11 due to severe malformations in structures that originate from the 
three germ layers, e.g. the neural tube, somites and gut tube (Ang and Rossant 1994; Weinstein, 
et al. 1994). Information about all the liver-specific Foxa target genes together with the 
observation that the Foxa genes are expressed very early during the formation of the definitive 
endoderm in the mouse, led to the theory that the Foxa proteins have important functions in 
mammalian liver development (Le Lay and Kaestner). In the liver, all three Foxa members are 
expressed, but neither of them is alone required for hepatogenesis indicating redundancy. 
However, using conditional knockouts it has been demonstrated that Foxa1 and Foxa2 together 
are necessary for the induction of liver specification (Lee, et al. 2005).  
Foxa2 is in addition reported to be expressed in the developing thyroid (Monaghan et al. 1993; 
Sato and Di Lauro 1996), although the documentation (by in situ hybridization) was rather poor 
and could not be referred to a specific cell type. Foxa2 have been shown to regulate the calcitonin 
gene (Viney, et al. 2004), suggesting that it is expressed in differentiated C-cells. Whether Foxa2 
(or Foxa1) is a biomarker of embryonic C-cells and their ancestors was investigated in paper II.  
Grj"tgegrvqtu"cpf"grjtkpu""
The Eph-ephrin receptor-ligand system is emerging as a novel principle of regulation in the 
embryonic development of possibly all organ systems. It has been most thoroughly investigated 
in the nervous system, from which many of the basic concepts of molecular interactions and 
cellular effects originate. Ephs and ephrins are implicated also in the development of different 
organs from the endoderm, e.g. intestine, pancreas and thymus (Islam, et al. ; Konstantinova, et 
al. 2007; Munoz, et al. 2009). No studies have so far investigated a putative role of Eph-ephrin 
signalling in the thyroid gland. In papers III and IV the expression pattern and function of the 
EphA4 receptor in the developing and adult thyroid were addressed. General and specific features 
of the Eph-ephrin system will be presented here to give the necessary background for the 
discussion of these papers.   
Jkuvqt{"cpf"encuukhkecvkqp"
The first Eph gene was discovered in an erythropoietin-producing human hepatocellular 
carcinoma cell line (ETL-1) more than twenty years ago (Hirai, et al. 1987). Some years later, in 
1994, the first report on an Eph family receptor interacting proteins (ephrins) was published 
(Beckmann, et al. 1994). The main features of Ephs and ephrins discussed at that time was the 
repulsive effects on developing axons guiding the growing neuronal processes toward their 
terminal destination. Since then, both the number and functions of Eph and ephrins identified in 
vertebrates have increased and diversified. Both the ligands and the receptors are membrane-
bound molecules expressed on adjacent interacting cells. 
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There are 14 Ephs and 8 ephrins in mammals, which therefore makes them the largest family of 
receptor tyrosine kinases (RTK). Both Eph receptors and ephrin ligands are divided into two 
subclasses, A and B, based on structural homologies and preferable binding partners (1997; 
Murai and Pasquale 2003). There are nine EphA (EphA1-EphA8 and EphA10) and five EphB 
(EphB1-EphB4 and EphB6) receptors. All Eph receptors are monomeric transmembrane proteins 
consisting of a extracellular part that contains the N-terminal ephrin binding domain, a cystein-
rich region and two fibronectin type-III repeats, and an intracellular/cytoplasmic part which 
includes four functional units, a juxtamembrane domain, a tyrosine kinase domain, a sterile ?-
motif (SAM) and the PDZ-domain binding motif (Figure 6). Functional aspects of the most 
important receptor domains will be discussed in the following paragraphs. 
The A-class ligands (ephrinA1-A5) are membrane-anchored by a glycosylphosphatidylinositol 
(GPI) moiety and bind typically to EphA-class receptors. B-class ligands (ephrinB1-B3) are 
transmembrane molecules with an extracellular domain that binds to EphB-class receptors and an 
intracellular terminus that possesses signalling properties (Figure 6) (further discussed below). 
The Eph-ephrin interactions are promiscuous within each class (A or B), but the binding affinities 
vary significantly (Himanen, et al. 2004; Pasquale 2004). Exceptions to this rule are EphA4 and 
EphB2 that can bind both A- and B-type ephrins (Himanen et al. 2004; Pasquale 2004). In 
contrast to other RTKs subfamilies, Eph receptors often show redundant functions within a class 
as a result of overlapping expression pattern and similar binding affinities towards the ephrins. 
This makes functional analysis in e.g. genetically modified mice (Eph/ephrin knock-out/knock-
in) difficult and complicated.  
 
Figure 6 .  An illustration, which shows an ephrin-A and ephrin-B-expressing cell (top) and an Eph-
expressing cell (bottom). GPI, glycosylphosphatidylinositol;  SAM, sterile ?-motif; P, phosphates; 
LBD,Ligand Binding global Domain.  
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Nkicpf/tgegrvqt"dkpfkpi""
Because both Ephs and ephrins are membrane-bound intimate cell-cell contact is required for 
binding and signalling. Downstream effects of Eph receptor activation is referred to as forward 
signalling. However, during receptor-ligand binding Ephs often acts as a ligand that elicits a 
receptor response in the cognate ephrin, leading to reverse signalling in the ephrin-expressing 
cells. The dual ability of the receptor-ligand complex to function in both a forward and a reverse 
fashion, mimicked only by the semaphorin/semaphoring receptor system (Pasquale 1997) is 
known as bidirectional signalling. 
 A feature that distinguishes the Eph–ephrin system from other RTKs is that the classical 
activation of RTK by receptor dimerization is not sufficient, but requires formation of a 
multimeric Eph/ephrin complex that creates a big cluster for robust Eph autophosphorylation and 
transmission of a biological response (Vearing and Lackmann 2005). Monovalent interaction 
between Ephs and ephrins is the first step followed by the formation of a heterodimer complex. 
Tetramerization occurs by the binding of two Eph-ephrin heterodimers, which initiates 
autophosporylation of their respective cytoplasmic domains. Biochemical and X-ray 
crystallographic investigations have generated abundant structural information about the 
interacting domains of the EphB2 and ephrin-B2 forming a complex (Himanen and Nikolov 
2003; Himanen, et al. 2001). The result shows that a large intermolecular interface is established 
during high-affinity ligand-receptor dimerization, whereas a second smaller interface is 
responsible for the assembly of the dimers into tetramers. More specifically, the ligand-receptor 
dimerization interface centres on the long G–H loop of ephrin-B2, which is inserted into a 
channel on the surface of EphB2. The EphB2 loops forming the sides of this channel are 
unstructured in the unbound receptor but are folded upon ligand binding to generate an extensive 
interaction surface that is complementary to the ligand G–H loop. Recently the crystal structures 
of EphA2/ephrin-A1 and EphA4/ephrin-B2 complex have been investigated (Himanen, et al. 
2009; Himanen and Nikolov 2003; Qin, et al. 2010). 
Hqtyctf"ukipcnnkpi"
The initial step after binding of ligand is autophosphorylation of tyrosine residues located in the 
intracellular part of the Eph receptor (Kalo and Pasquale 1999). For complete activation of the 
receptor tyrosine kinase autophosphorylation of the juxtamembrane tyrosine residues is required 
(Binns, et al. 2000; Kullander, et al. 2001). This allows the juxtamembrane domain to be released 
from the interaction with the kinase domain converting it into an active state (Wybenga-Groot, et 
al. 2001). 
Once the receptor is activated, adaptor molecules associate with its cytoplasmic tail to transmit 
signals into the cell. Adaptor proteins are a growing class of proteins that contain functional 
protein-interaction domains, such as SRC-Homology-2 (SH2) and SH3 domains, but often lack 
intrinsic enzymatic activity. Downstream signalling from Eph receptors in which adaptor proteins 
participate involves e.g. cell shape changes by Rho activation, cell proliferation through the 
mitogen activated protein kinase (MAPK) pathway, cell-cell adhesion via cadherin complexes 
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and cell-matrix interactions by means of altered expression and binding properties of integrins 
(Noren and Pasquale 2007; Pasquale 2005). 
Signalling connections that may apply only to a particular Eph class are the exchange factors 
Ephexin (Eph-interacting exchange factor) for EphA receptors and intersectin and kalirin for 
EphB receptors. Ephexin is a guanine nucleotide exchange factor for Rho-family GTPases that 
directly interacts with the EphA receptors. When Ephrin-A bind to EphA the activity of Ephexin 
leads to RhoA activation and Cdc42/Rac1 inhibition, which in turn reorganize the cytoskeleton 
and cell morphology changes (Shamah, et al. 2001). Other examples of selectivity are the lipid 
phosphatase Ship2 found to interact only with EphA2, and the GTPase-activating proteins 
SPAR/E6TP1 interacting only with EphA4 and EphA6 (Richter, et al. 2007; Zhuang, et al. 2007). 
Tgxgtug"ukipcnnkpi"
B-class ephrins mediate reverse signalling of importance for a number of morphogenetic events 
mostly notified in the central nervous system. Examples of this are axon guidance (Cowan, et al. 
2004; Pasquale 2005), cell migration (Lu, et al. 2001), midline fusion (Dravis, et al. 2004), 
plasticity (Armstrong, et al. 2006) and synaptogenesis (Kayser, et al. 2006). Activation of ephrin-
Bs through binding to a cognate Eph receptor leads to the recruitment of Src-family kinases that 
phosphorylate tyrosine residues on the cytoplasmic domain. This leads to a conformational 
change that is more favourable for signalling. Phosphorylated ephrin-B serves as a docking site 
for SH2-containing adaptor proteins, such as Grb4, which then activate signalling pathways 
ultimately leading to changes in the actin cytoskeleton and focal adhesions (Cowan and 
Henkemeyer 2001). B-type ephrins also have a carboxyl-terminal PDZ domain-binding site that 
recently was shown to be functionally important (Egea and Klein 2007). 
Much less is known of the reverse signalling mechanism of Ephrin-As as these are anchored to 
the cell membrane by a GPI linkage and lack an intracellular domain. To signal ephrin-A must 
associate with other transmembrane proteins capable of activating intracellular signalling 
pathways. One example of this is the association of p75 with ephrin-A resulting in a functional 
complex in which p75 acts as co-receptor or signalling partner (Lim, et al. 2008). 
Cvvtcevkqp"*cfjgukqp+"xgtuwu"tgrwnukqp"
Ephs and ephrins control cell positioning during normal and oncogenic development by 
modulating cell-cell adhesion and cell-cell repulsion. A repulsive response involving the 
retraction of cellular processes was in fact the first discovered outcome of Eph forward signalling 
(Flanagan and Vanderhaeghen 1998). The physiological importance of Eph-ephrin mediated 
adhesive effects is highlighted by the defects in midline fusion of the neural tube observed in 
ephrin-A5 knockout mice (Holmberg, et al. 2000). These defects lead to severe congenital 
malformations including craniofacial malformations and anencephaly (Holmberg et al. 2000) 
Whether Eph-ephrin interactions result in adhesion or repulsion are dependent of the class of 
molecules and cell types involved and on the presence of modulating binding partners. As Eph 
and ephrin binding occurs through high-affinity interactions, the expected outcome would be a 
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close adhesion between the cells. However, the transient binding between an Eph receptor and the 
cognate ephrin tethered to the cell membrane usually results in contact-mediated repulsion. To 
accomplish this termination of receptor-ligand binding after initial activation and signalling is 
therefore a crucial event. 
Recent findings indicate that the dissociation of complex-bound Ephs and ephrins is a highly 
regulated process involving endocytosis or ectodomain cleavage (Egea and Klein 2007). In 
cultured cells binding of EphB and ephrin-B results in the rapid formation of intracellular vesicles 
containing EphB-ephrin-B complexes. Interestingly, the endocytosed complex includes full-
length proteins indicating that one of either the receptor or the ligand are trans-endocytosed from 
one cell to the other nearby (Mann, et al. 2003; Marston, et al. 2003; Zimmer, et al. 2003). Rac 
activity and actin polymerization in the Eph expressing cell have been shown to play an 
important role in the internalization of the receptor-ligand complex and repulsion of endothelial 
cells (Marston et al. 2003). However, putative signals elicited by or possible impacting on the 
endocytosis are poorly understood. So far no studies have confirmed that this mechanisms 
operates in vivo to regulate adhesion and repulsion. 
Release of cell surface-bound ephrin ligands by A-Disintegrin-And-Metalloprotease (ADAM) 
transmembrane metalloproteases is another mechanism by which cell behaviors switches from 
adhesion to repulsion. ADAM10 is located on Eph expressing cells and cleaves the ephrin from 
its membrane tether thereby breaking the intercellular connection and allowing the ligand-
receptor complex to internalize (Janes, et al. 2009). In general, ADAM function is enhanced 
when the Eph kinase is active and repressed when the kinase is inhibited. In vitro studies have 
showed that tyrosine phosphorylation of EphA3 generates a measurable movement of the kinase 
domain away from the plasma membrane. Only this positional change of the EphA3 kinase 
domain permits ADAM10 to come close enough to cleave the tightly bound ephrin-A5 from its 
plasma membrane anchor (Janes et al. 2009). The ephrin fragment retained in the membrane are 
further cleaved by ?-secretase followed by proteasomal degradation (Janes et al. 2009).  
Grj"cpf"grjtkpu"kp"gctn{"fgxgnqrogpv""
The expression of Ephs and ephrins is induced in a distinct spatiotemporal pattern during several 
important developmental stages including gastrulation, segmentation, somitogenesis and 
organogenesis. EphB3 is a good example of these dynamics. Already at the gastrulation stage 
EphB3 is detected in the primitive streak in chick embryos, but the expression is extinguished 
once the cells have ingressed (Baker, et al. 2001).  Somewhat later EphB3 is strongly transcribed 
in the floor of the foregut, the anterior lateral endoderm and in the underlying cardiogenic 
mesoderm, and transiently expressed in the lateral ectoderm, neural tube, and neural crest. In the 
developing brain, EphB3 expression is restricted to the mesencephalon. Similar changes are 
observed in mesoderm-derived tissues: at first EphB3 is expressed in the sclerotome and in 
somitic mesoderm, but later on in development EphB3 is predominantly found in the dermatome. 
In addition, EphB3 is detected in the developing heart, liver, posterior ventral limb bud 
mesenchyme, pharyngeal arches, and head mesenchyme (Baker et al. 2001), illustrating the 
pluripotency of Ephs in vertebrate development.  
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Similar to EphB3, ephrin-A1 transcript is first detected in the primitive streak and in addition in 
the developing allantois. At embryonic day 8-8.5 ephrin-A1 is expressed in the anterior 
pharyngeal endoderm and in the presumptive endocardial cells, dorsal aorta and primary head 
veins. Later on ephrin-A1 is detected in intersomitic vessels and the limb bud vasculature; each 
position of ephrin-A1 expression correspond to regions of vasculogenesis or angiogenesis 
(McBride and Ruiz 1998). This explains why ephrin-A1 null mice are early embryonic lethal due 
to impaired cardiovascular development.   
Dkqnqikecn"ghhgevu"
The complexity of Eph-ephrin interactions is illustrated by the high diversity of biological 
outcomes, which can be distinguished at the single cell level, in tissue patterning, and in 
organogenesis in which the final anatomy such as organ size may be influenced. As many of 
these aspects are considered in the interpretation of data presented in papers III and IV, major 
achievements on the physiological roles of Ephs and ephrins will be briefly highlighted in the 
following order: cell migration, cell proliferation, tissue patterning, epithelial homeostasis, and 
organ-specific effects (nervous system, cardiovascular system, intestine and glands). The 
contribution of defective or aberrant Eph-ephrin signalling in cancer and other disease will also 
be summarized. Eventually, the current knowledge of EphA4-mediated effects in mice will be 
pointed out as a prelude to the discussion of thyroid phenotypes in EphA4 mutants. In all 
instances, the presentation is to exemplify rather than provide a comprehensive review. 
Cell migration 
Locomotion is a fundamental cell behaviour that can be adopted by most cells in environments 
that promote changes in the cytoskeleton and adhesiveness characterizing the migrating 
phenotype. Regulation of the migration and adhesive interactions of cells is fundamental for the 
assembly and maintenance of organized tissues during animal development. Eph and ephrins are 
essential for these processes and have a number of interesting and characteristic properties that 
may underlie the mechanism by which they control cell adhesion and the assembly of the actin 
cytoskeleton. Repulsive Eph signals constrain the organization, and prevent the intermingling of 
subpopulations of cells that are marked by differential Eph or ephrin expression. This generates 
interfaces where Eph bidirectional signalling stabilizes patterns of cellular organization. 
Neural crest cells (NCC) have been called the ‘explorers of the embryos’ because they migrate all 
over the embryo and differentiate into a diverse variety of cells. NCC arise by the delamination of 
cells from the dorsolateral edge of the neural epithelium, and migrate along a variety of pathways 
to specific destinations (Bronner-Fraser 1993). The NCC is one of the most pluripotent 
embryonic tissues as the progeny develop into such different cells and tissues as ganglionic 
neurons of the peripheral nervous system and craniofacial cartilage, bone and skeletal muscles 
cells. To reach the final destination streams of NCC cohorts migrate long distances in which Ephs 
and ephrins appears to play modulatory roles. For example, in Xenopus embryos, cranial NCC 
migrating throw the third arch express EphA4 and EphB1, whereas the neighbouring second arch 
and crest cells express ephrin-B2 (Smith, et al. 1997). Ephrin-B2 is known to interact with both 
EphB1 and EphA4. Further experiments with truncated EphA4/EphB1 receptors and ephrin-B2 
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showed that these molecules are involved in restricting the intermingling of second and third arch 
neural crest and specifically in guiding third arch neural crest to the accurate destination (Smith et 
al. 1997). 
Cell proliferation 
In contrast to most RTKs that typically bind peptide growth factors, it is much more unusually for 
Eph receptors to have a direct role in mitogenesis. Whereas other RTKs activate the mitogen 
activated protein kinase (MAPK)  pathway, Eph receptors can also work the other way around 
and  have an inhibiting effect on the MAPK pathways (Miao, et al. 2001). However, it is clear 
that Ephs modulate cell proliferation impacting on organ size (Munoz, et al. 2006; North, et al. 
2009). It is also evident that Eph signalling can regulate the balance of stem cell renewal versus 
differentiation and fate determination in a spatially regulated manner. In the epithelium of the 
small intestine opposing gradients of EphB2/EphB3 and ephrin-B1/ephrin-B2 along the crypt–
villus axis influence stem cell renewal by controlling cell positions, which in turn determines the 
exposure of cells to growth factors that emanate from the bottom of the crypts (Holmberg, et al. 
2006). These data establish that ephrins and Eph receptors are key players of migration and 
proliferation of the intestinal stem cell niche. 
Tissue patterning 
The expression pattern of Eph receptors and ephrins is known to restrict cell movements between 
hindbrain segments. The hindbrain is subdivided into rhombomers consisting of segmental units 
that organize nerves and streams of neural crest cells that migrate into the branchial arches. The 
rhombomers are established by the segmental expression of genes such as Krox-20 required for 
the formation of segments, and by Hox genes that create the anterior-posterior axis in the embryo 
(Reviewed by (Lumsden and Krumlauf 1996; McGinnis and Krumlauf 1992; Sham, et al. 1993)). 
Specifically, EphA4, EphB2 and EphB3 are expressed at high levels in rhombomeres number 
r3/r5 (Henkemeyer, et al. 1994; Nieto, et al. 1992), whereas ephrin-B1, ephrin-B2, and ephrin-B3 
are expressed at high levels in r2/r4/r6 (Bergemann, et al. 1995; Flenniken, et al. 1996; Gale, et 
al. 1996a) se fig Wilkinson (Wilkinson 2000). The repulsive action of ephrin-B ligands thus 
makes cells expressing the ligand in even numbered rhombomeres to move away from cells 
expressing the Eph receptors in odd numbered rhombomeres. This mechanism of creating tissue 
boundaries is recognized also in other developmental processes, e.g. somitogenesis (Watanabe, et 
al. 2009) suggesting it is a general principle of tissue patterning. 
Tissue homeostasis 
Eph and ephrins are essential for the embryonic and postnatal development of epithelial tissues, 
as well as having an important role in maintaining the epithelial tissue homeostasis in adulthood 
(Miao and Wang 2009). For example, EphB (EphB2 and EphB3) and ephrin-B2 proteins are 
involving in the homeostasis of the gastrointestinal tract, where signalling regulates cell sorting in 
the mature epithelium (see Cell proliferation). There is a number of different cell lineages in the 
villus region, which are continually renewed and shed into the intestinal lumen (Holmberg et al. 
2006). In the mature intestine, four epithelial cell types derive from stem cells in the crypts. Three 
of the cell types move upward, out of the crypts and onto the villi as they differentiate. The 
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fourth, the Paneth cell, moves to the base of the crypt. EphB2 and EphB3 forward signalling 
promotes cell-cycle re-entry of intestinal progenitor cells (Holmberg et al. 2006). 
During cell migration, when newly generated epithelial move away from the source of Wnt 
secreted by surrounding mesenchymal cells at the bottom of the crypt, the epithelial cells 
gradually lose EphB expression and obtain ephrin-B expression. This generates counter-gradients 
of EphB and ephrin-B expression along the crypt axis, with high EphB expression at the bottom 
of the crypts and high ephrin-B expression at the top and in the villi. The canonical Wnt/?-
catenin/Tcf signaling pathway is an essential regulator of homeostasis in the intestinal epithelium, 
mainly by its ability to support the transcription of EphB receptors and inhibit that of ephrin-B 
ligands (Clevers and Batlle 2006). 
Eph and ephrin signalling is implicated also in maintaining skin epithelial homeostasis. In mouse 
epidermis, EphA2 and ephrin-A1 are expressed in a complementary pattern in the different cell 
layers as the keratinocytes mature. EphA2 is expressed in a basal to suprabasal gradient with 
lower expression in the basal layer and higher expression in spinous and granular layers. In 
contrast, ephrin-A1 expression is mostly limited to the basal layer next to the basement 
membrane. It is suggested that EphA2/ephrin-A1 interactions in the basal layer serve to regulate 
cell proliferation taking place only in this location (Miao and Wang 2009). EphB-ephrin-B 
binding between osteoblasts and osteoclasts has been implicated in the regulation of bone 
homeostasis in the adult (Zhao, et al. 2006). The communication between osteoclasts and 
osteoblasts is bidirectional and EphB4 and probably other co-expressed Eph receptors promote 
the forward signalling thereby maintaining bone homeostasis (Zhao et al. 2006). 
Nervous system  
Eph receptors and ephrins are abundantly expressed in the developing nervous system in which 
the organization of neuronal connectivity by guiding axons to the correct target cells and tissues 
and the formation of synaptic contacts are regulated. The literature in this field is vast, and here 
only few examples of effects of particular interest to the thesis studies will be given. 
EphA4 was originally found to be a fundamental component in the neuronal circuitry controlling 
movement due to its regulating function in axon guidance and cell migration in the developing 
central nervous system (Kullander et al. 2001). Corticospinal tract axons need EphA4 to identify 
the spinal cord midline as an intermediate repulsive target that prevents them from aberrantly 
recrossing. As a result to this, homozygous EphA4 knock-out mice display severe motor 
dysfunctions resulting in reduced and uncoordinated locomotor performance and a kangaroo-like 
gait (Dottori, et al. 1998; Kullander, et al. 2003).  It have been shown that EphA4 has a non-cell-
autonomous roll, no EphA4 forward signalling is required, in the axon bundle that connects the 
two cerebral hemispheres, called the anterior commisure (Cowan et al. 2004; Kullander et al. 
2001). EphA4-positive neurons are also important components of the spinal central pattern 
generator (Kullander et al. 2003). Central pattern generator is a local neuronal network within the 
spinal cord that generates and coordinates rhythmic muscle activities responsible for coordinated 
bilateral control over the normal limb alternation that underlies walking (Butt and Kiehn 2003; 
Kiehn and Kjaerulff 1998). 
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Topographic mapping of thalamocortical axons requires EphA4 expression. Using genetically 
modified mice expressing different forms of truncated EphA4 receptors Dufour et al. found that 
the tyrosine kinase domain of EphA4 is required for the projection of thalamocortical axons, 
whereas the PBM and the SAM domains are not essential (Dufour, et al. 2006).  
Cardiovascular system 
Numerous Eph-ephrin interactions have been identified in the developing cardiovascular system, 
but EphB4 and its ligand ephrin-B2 are the most studied ones. Ephrin-B2 is expressed in arterial 
endothelial cells, whereas EphB4 is mostly expressed in veins. Both are crucial for angiogenic 
remodelling and survival of the embryo (Wang, et al. 1998). During angiogenesis, EphB4 and 
ephrin-B2 interacts in two different ways. First in the borders of the venous and arterial 
capillaries, it makes sure that arterial capillaries connect only to venous ones. Second, in non-
border areas, it ensures that the fusion of capillaries to make larger vessels occurs only between 
the same types of vessels. Additional information about signalling pathways that interact with 
EphB4/ephrin-B2 to establish arterial–venous specification is emerging. One is the Notch 
pathway, the repression of Notch signalling resulted in the loss of ephrin-B2-expressing arteries 
and their replacement of veins. Conversely, activation of Notch signalling suppressed venous 
development, causing more arterial cells to form (Lawson, et al. 2002).  
EphA4 is expressed on endothelial cells in the vasculature of the developing nervous system 
(Goldshmit, et al. 2006). This pattern of expression is not retained in the adult animal. 
Experiments in wild-type mice have shown that after spinal cord injury (causes direct vascular 
damage and initiates a cascade of events that alters the permeability of the blood–brain barrier) 
the expression of EphA4 is clearly up-regulated on activated astrocytes, many of which are 
tightly associated with blood vessels (Goldshmit et al. 2006). In injured spinal cord of EphA4 
knock out animals astrocytes were not as tightly associated with blood vessels as the wild-type 
astrocytes. These results suggest an additional role for the EphA4 receptor in vascular 
development and repair of the blod brain barrier after spinal cord injury (Goldshmit et al. 2006). 
Intestine 
The small intestinal epithelium is composed of crypt-villus elements, with the function to absorb 
water and nutrients. An additional role is to function as a protecting barrier against pathogens. 
The intestinal epithelium undergoes continuous self-renewal throughout life, and homeostasis is 
maintained by the balance of cell proliferation, differentiation, and apoptosis. As previously 
discussed, it is known that signalling between EphB and ephrin-B regulates cell proliferation in 
the small intestine (Holmberg et al. 2006). This is reflected by the expression pattern along the 
crypt-villus axis: EphB2 is strongly expressed on cell membranes at the bottom of the crypt, with 
decreased expression on cells higher in the crypt. In addition, EphB3 is strongly expressed on 
cells in the crypt base. In contrast, ephrin-B1 and -B2 expression is low on cells at the bottom of 
the crypt and increased on cells higher in the crypt0 
Ephs and ephrins also appear to have an important function during the embryonic development of 
the small intestine. All family members, with the exception of EphA5, have been shown to be 
expressed throughout the intestine at all ages although at different levels (Islam et al.). EphA4, 
EphA8, EphB4, and ephrin-B2 expression are on maximal levels during embryonic life, 
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suggesting that they may have an important role in intestinal morphogenesis. Sustained 
expression of other family members in the mature intestine may indicate regulatory roles in 
enteric differentiation (Islam et al.).  For example; Batlle at al. have looked at EphB2- and 
EphB3-null mice that demonstrated that the normal upward and downward movement of different 
cell types in the intestine was disordered (Batlle, et al. 2002). Moreover, it has been reported that 
signalling between EphB2 and ephrin-B2 regulates cell proliferation in the small intestine 
(Holmberg et al. 2006), and expression of mouse EphA2 has been identified in E7.5 endoderm 
and persists through E10.5, suggesting a possible role in early patterning of the gut tube (Moore-
Scott, et al. 2007)."
Glands 
The mammary gland develops mainly postnatally, at difference with most other branching organs 
that are established during embryogenesis. EphB4 is the most extensively studied Eph receptor 
implicated in mammary morphogenesis. EphB4 is primarily expressed in myoepithelial cells, and 
its ligand ephrin-B2 is expressed in luminal epithelial cells, in an estrogen-dependent manner 
(Nikolova, et al. 1998). The expression of both EphA4 and ephrin-B2 is turned on at the onset of 
puberty and is differentially regulated during the estrous cycle. During pregnancy both the 
receptor and its cognate ligand is downregulated and transcriptionally silent for the duration of 
lactation, after which they are re-induced (Munarini, et al. 2002). Together this suggests that 
EphB4-ephrin-B2 bidirectional signalling regulates cell proliferation in the mammary gland. 
Recently, it was shown that also EphA2 and its ligand ephrin-A1 are required for mammary 
epithelial growth and branching morphogenesis (Vaught, et al. 2009). Loss of EphA2 inhibits the 
proliferation of the mammary epithelium and delays ductal branching essential for complete fat 
pad filling (Vaught et al. 2009). 
Pancreas develops from the embryonic forgut endoderm. Pancreatic development begins with the 
formation of ventral and dorsal buds. Differential rotation and fusion of the ventral and dorsal 
pancreatic buds results in the formation of the definitive pancreas consisting of exocrine and 
endocrine tissues."During development more or less all ephrins and their receptors are expressed 
in pancreatic progenitors that are expected to give rise to exocrine acini, but they are hardly 
detected in the more central parts from which intra-pancreatic ducts and endocrine cells derive 
(van Eyll, et al. 2006). EphA4 is the only receptor that is not expressed during pancreatic 
development."
Recent findings indicate that Eph-ephrin bidirectional signalling modulate the function of the 
insulin-producing ?-cells in the adult pancreas. The ?-cells adjust their secretion of insulin in 
response to glucose levels in the blood in order to maintain glucose homeostasis in the body. 
When the glucose concentration is low, several EphA receptors are tyrosine phosphorylated and 
initiate forward signalling that holds back insulin secretion. In contrast, at high glucose 
concentrations reverse signalling mediated by the ephrinAs promotes insulin secretion. In fact, 
ephrin-A5 knockout animals had a significantly reduced glucose-stimulated insulin secretion 
(Konstantinova et al. 2007). 
Thymus is a specialized organ of the immune system in which the T-lymphocytes mature into 
immunocompetent cells. Cortical and medullary thymic epithelial cells from both the embryonic 
and the adult thymus express several Eph and ephrins, in particular those of the B family. EphB2 
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and ephrin-B2 are expressed on both thymocytes and epithelial cells. Functional studies in EphA4 
knockout mice show defects in thymocyte maturation and a decreased numbers of peripheral T-
lympocytes. In addition, the EphA4-/- thymus is hypocellular and the size of the gland is very 
much reduced (Munoz et al. 2006). These defects appear to result from abnormal development of 
EphA4-expressing stromal cells in the thymic cortex leading to impaired thymocyte maturation 
and survival. 
Cancer 
Protein tyrosine kinase genes are the largest family of oncogenes. Activating mutations  leading 
to constitutive stimulation of signal transduction pathways that control cell shape, proliferation, 
differentiation, and migration are key events in carcinogenesis and tumour progression. As Ephs 
represent the largest family of receptor tyrosine kinases it is not surprising that aberrant Eph 
signalling is frequently recognized in cancer. 
Many Eph receptors are over-expressed in a variety of cancers. In most cases this is associated 
with tumour-promoting features, although sometimes Ephs may inhibit tumorigenesis. The 
founding member of the Eph family, EphA1, was isolated from a hepatoma cell-line (Hirai et al. 
1987) and is over-expressed in liver, lung, breast and colon carcinomas (Pasquale 2010). In 
metastatic tumour cell lines the expression levels of both Ephs and ephrins are often higher than 
in the primary tumours, correlating with the grade of the tumour malignancy and invasiveness. 
EphB4 present in all examined breast carcinoma cell lines is of particular interest since it has both 
tumour-suppression and tumour-promoting activities. A hypothesis is that high levels of ephrin 
dependent EphA2 forward signalling suppress tumorigenesis whereas low levels of forward 
signalling promote. Indeed, EphB4 forward signalling inhibits breast cancer cell tumorigenicity 
both in vitro and in vivo when its tyrosine kinase activity is stimulated by a soluble form of the 
ligand, ephrin-B2 Fc (Noren and Pasquale 2007). EphB4 can also promote tumorigenesis in 
breast cancer cell lines, by stimulating ephrin-B2 reverse signalling, inducing angiogenesis 
(Noren, et al. 2004).  
Among the first Eph/ephrin mutations associated with human diseases were identified in prostate 
cancer cells, comprising the EPHB2, EPHA3 and ephrin-B1 (EFNB1) genes. Huusko et al. have 
described EphB2-dependent growth inhibition of prostate cancer cells (Huusko et al. 2004) .  
Other diseases 
Craniofrontonasal syndrome; a developmental disorder mainly characterized by skeletal 
abnormalities have been linked to heterozygous EFNB1 mutations that impair the expression and 
function of ephrinB1 in the affected embryonic tissues (Wieland, et al. 2004). The disease 
phenotype is probably the result of abnormalities in the formation of embryonic tissue 
boundaries. EFNB1 is located on the X-chromosome. Interestingly, the disease is much more 
severe in females than in males even though only females retain one wild-type EFNB1 allele. 
(Twigg, et al. 2004; Wieland et al. 2004). An explanation to this seemingly contradictory finding 
is the ephrins ability to drive cell sorting. In mouse models of this syndrome, the sorting of 
ephrin-B1-positive and ephrin-B1-negative cells as a result of X-inactivation in heterozygous 
females disturbs the patterning of skeletal structures more severely than in males and 
homozygous females, in which all cells lack ephrin-B1. 
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EphA4  
The thyroid has never before been investigated for Eph and ephrin expression. We found that 
EphA4 is detected in the thyroid bud by transcriptome analysis (paper III), and characterized its 
expression pattern and function in the thyroid both during embryonic development and post-
natally (papers III and IV). Although already mentioned and discussed in previous paragraphs, 
EphA4-mediated effects in mouse will be shortly summarized to finalize the introduction part of 
the thesis. As EphA4 is one of the most thoroughly studied Eph receptors (comprising 283 hits in 
PubMed search April 2010) only some of its multiple features and signalling effects will be 
further commented on. 
EphA4 is an exception from the rule that EphA receptors only bind ephrin-A ligands and EphB 
receptors only bind ephrin-B ligands. Thus, apart from binding to several ephrin-As EphA4 has 
affinity for all three ephrin-B ligands (Gale, et al. 1996b; Wilkinson 2000). EphA4 binds ephrin-
B2 with weaker binding affinity than ephrin-As, depending on a loose fit of the ephrin-B2 G-H 
loop in the EphA4 ligand-binding channel (Bowden, et al. 2009) , however the biological effects 
are prominent. Because of the different strategies that EphA4 can use to bind ephrin-A or ephrin-
B ligands, it is generally considered that EphA4 achieves the highest promiscuity among the Eph 
receptors (Qin et al.). Illustrating examples of this are EphA4 interactions with ephrin-B2 (and 
ephrin-B3) that regulate cell sorting in the rhombomeres and branchial arches of the developing 
hindbrain (Smith et al. 1997), axon guidance and circuit formation in the developing spinal cord 
(Kullander et al. 2003; Kullander et al. 2001), somite morphogenesis (Barrios, et al. 2003) and 
inhibition of axon outgrowth by myelin (Benson, et al. 2005). The restricted expression of EphA4 
in rhombomeres 3 and 5, i.e. in between the adjacent ephrin-B expressing rhombomeres number 
2, 4 and 6 (Henkemeyer et al. 1994; Nieto et al. 1992), signifies the importance of EphA4 in 
morphogenetic patterning during embryogenesis. In a later developmental stage this keeps a 
restricted distribution of neural crest cell (NCC) subpopulations when these migrate from the 
rhombomeres into the corresponding brachial arches. EphA4-ephrin-B1 binding stabilizes blood 
clot formation (Prevost, et al. 2005).  
Interestingly, in the EphA4 knock-out mouse Kullander et al. saw that some EphA4 heterozygous 
animals show the same phenotype as homozygous animals (Kullander et al. 2003), indicating that 
both alleles are transcribed and required for function. The central pattern generator controls the 
alternations that underlie the right and left limb movements in walking. Mice deficient for EphA4 
have lost left-right limb alternations and instead move the limbs in a synchronized manner 
(Kullander et al. 2003). Looking at EphA4-mediated forward signalling regulation of 
thalamocortical neuronal projections Dufour et al. recently showed that 43% of the mice deficient 
for EphA4 have an abnormality in the thalamocortical system whereas the same phenotype is 
observed in 25% of the heterozygous mutants (Dufour et al. 2006). Surprisingly, in EphA4-EGFP 
mice, in which the whole intracellular part of the receptor is exchanged for a EGFP molecule, the 
characteristic mutant abnormalities showed a much higher penetrance in the corresponding 
homozygous mutants (50% in EphA4EGFP/EGFP, 83% in EphA4+/EGFP) (Dufour et al. 2006). The 
phenotype observed in heterozygous animals thus seems to be due to a dominate-negative effect 
of the truncated EphA4 receptor (Dufour et al. 2006). 
 "
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CKOU"QH"VJG"UVWF["
The thesis work concentrated on four separate although partially linked issues of either 
incomplete, controversial or yet unknown status in the developing thyroid gland. The overall aim 
was to illuminate and possibly uncover some of the morphogenetic and molecular mechanisms of 
interest to the understanding of thyroid growth and function and distinct pathologies of the gland. 
The specific aims of the included papers were: 
 
I." Provide a detailed map of thyroid morphogenesis in the mouse embryo, focusing on 
spatiotemporal patterns of growth and relationship to adjacent embryonic tissues and 
structures (mesoderm, vessels). 
 
II." Identify novel biomarkers of mouse C-cell precursors to better characterize their 
embryonic origin and transport into the developing thyroid. 
 
III." Investigate the expression pattern of EphA4 in thyroid primordial tissues and putative 
thyroid phenotypes in mice deficient of EphA4 or expressing a truncated receptor. 
 
IV." Characterize thyroid growth and function responses in EphA4 mutant mice. 
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TGUWNVU"CPF"FKUEWUUKQP"
Fgxgnqrogpv"qh"vjg"hqnnkewnct"egnn"nkpgcig"
Qtkikp"qh"rtqigpkvqt"egnnu"
In normal development, the thyroid primordium is first distinguished as a thickening of the 
anterior foregut endoderm at the base of the prospective tongue. This thickening is termed the 
thyroid placode, it can be distinguished from the rest of the endoderm by their co-expression of 
four transcription factors, Nkx2.1, Foxe1, Hhex, Pax8. These transcription factors have central 
functions in other embryonic tissues as well, but it is only in the thyroid the combination of all 
four can be found. The process leading to the organization of the thyroid placode is termed 
specification. 
Congenital hypothyroidism  is the most common congenital endocrine disorder affecting 
approximately 1 of 3500 newborns (Toublanc 1992), results from a partial or complete loss of 
thyroid function. To learn about a malfunction, it is important to have a detailed view of the 
normal process. In paper I we investigated the normal thyroid development in mouse embryos. 
The endoderm outside the placode was found to proliferates, although no BrdU incorporation 
could be detected in the thyroid primodium. A likely explanation would be that the thickening of 
the endoderm expands by recruitment of more cells from the neighbouring endoderm. Earlier 
studies support this. Kinebrew and Hilfers studies (Kinebrew and Hilfer 2001) in chick embryos 
provides evidences that growth of the thyroid occurs by movements of individual cells and 
invasion of the nearby pharyngeal cells. The enlargement of the placode and budding to follow 
takes place in close relationship with the aortic sac (paper I), a large vessel that communicates 
with the primitive heart outflow tract and from which the pharyngeal arch arteries develop.  
EphA4 and several ephrins were found to be detected in the thyroid bud by transcriptome analysis 
(paper III). The EphA4 receptor was selected for further investigation. In this paper, we used an 
EphA4 receptor with the intracellular part exchanged for an EGFP (enhanced green fluorescent 
protein) molecule for in vivo localization of EphA4 protein. EphA4-EGFP was ubiquitously 
expressed in the anterior foregut endoderm including the thyroid placode in E9.5 embryos. At the 
budding stage, the thyroid progenitors continued to express EphA4, confirming the results from 
the transcriptome analysis. The specification and budding process proceed normally even when 
EphA4 was deleted (in EphA4 null mice). The results indicate that EphA4 signalling have no 
function for these early developmental stages. Another explanation would be that, as previous 
results have shown, other Eph receptors with similar expression pattern and ligand specificities 
may have overlapping functions and partially compensate for the loss of the EphA4 receptor so 
that the thyroid primodium can develops normally (Birgbauer, et al. 2000).  
It is generally believed based on the expressions pattern that Foxa2 (the forkhead box 
transcription factor A2) regulates thyroid development, although this has not been studied in 
more detail. Since Foxa2 is known to be broadly expressed in the definitive foregut endoderm 
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(Monaghan et al. 1993; Sasaki and Hogan 1993), it was first important to clarify whether Foxa2 
might be expressed also by progenitors of the follicular cell lineage during thyroid organogenesis 
(paper II). Strong Foxa2 expression was observed as expected in the floor plate and notochord at 
E9.5. In addition, the anterior endoderm showed Foxa2 immunoreactivity, although it was 
heterogeneous and preferentially located in the dorsal and ventral aspects of the foregut. Notably, 
Foxa2 expression was excluded from the zone in the foregut endoderm corresponding to the 
thyroid placode, identified by the transcription factor Nkx2.1. That the midline thyroid 
primordium did not express Foxa2 during budding was confirmed by analysing E10 embryos, 
moreover the detached bud was also lacking Foxa2, suggesting that the early developmental 
stages of the thyroid are Foxa2 independent.  
Godt{qpke"fgxgnqrogpv"
During the course of further development, the thyroid bud had assumed an elongated shape with 
the cranially part attached to the endoderm by the so-called thyroglossal duct. At this stage, the 
precursor cells are clearly separated from the aortic sac.  This is also the first time the cells are 
proliferating, and detected by BrdU (paper I). EphA4-EGFP expression can still be seen in the 
membrane of all thyroid progenitor cells (paper III). The thyroglossal duct disappears at 
embryonic day 11.5, and the bud is completely detached from the endoderm. Soon after, the 
developing thyroid starts moving in a caudal direction away from the endoderm, still holding the 
midline position. At this stage, the earliest sign of vascularisation can be observed in the cup-
shaped proliferating primordium that have re-established a close position to the cranial part of the 
aortic sac. In level with the third pharyngeal arch arteries, the midline thyroid primordium has 
reached the final position. The fluorescent signal from the EGFP molecule attached to EphA4s 
extracellular part was strong, even now when the thyroid primodium is a free body (paper III). 
For the thyroid to develop into its final butterfly-shape, with two lobes located in the anterior 
neck on the trachea just inferior to the larynx, it has to begin to grow bilaterally. During the 
bilobation process, the thyroid proliferates and extends laterally along the route of the third 
pharyngeal arch arteries towards the ultimobranchial bodies. The functional role that the nearness 
of the aortic sac might have for the developing thyroid is not apparent, although, some 
possibilities are suggested from data obtained in Tbx1-/- embryos. Mice deficient for Tbx1 were 
observed to have only a single thyroid lobe, this might be because of the lack of the re-established 
contact between the aortic sac and thyroid primodium. Data suggest that this re-association with 
the aortic sac guides the thyroid primodium along the third pharyngeal arch arteries, and that this 
event promote the bilobation process; without this contact in the mutant embryo only one single 
thyroid diminutive lobe is formed (Fagman, et al. 2007).  
At E13.5, the bilaterally outgrowing thyroid surrounds the ultimobranchial bodies and the two 
anlagen fuse forming the primitive thyroid lobes. Two days later, at E15.5 the growing thyroid 
lobes consist of cords of follicles in a star like pattern. The organization of the typical thyroid 
histoarchitecture has started and at E17.5 the thyroid lobes had increased further in size and the 
cordlike structures has developed into small follicles that accumulated thyroglobulin in the lumen 
(paper I). In the later part of thyroid development EphA4-EGFP was found in most of the 
expanding parenchyma of the thyroid lobes.  However, in the central parts of the lobe known to 
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harbour not yet scattered C-cells, there were cells undetectable for EGFP (paper III); this will be 
discussed in more detail later on. EphA4 deficient mice and EphA4-EGFP mutants were 
morphologically investigated. No apparent malformation could be found during the different 
developmental stages when compared to wild type embryos (paper III). The present findings 
suggest that midline thyroid follicular development is independent of both forward and reverse 
EphA4 signalling. Foxa2 can still not be detected in progenitors from the lateral thyroid 
primodium (paper II). 
Rquv/pcvcn"fgxgnqrogpv"
In paper III we searched for possible structural abnormalities in the adult thyroid gland in both 
EphA4 knockout animals and EphA4-EGFP mice in which the intracellular forward-signalling 
domain is missing. All these animals were clinically euthyroid and the thyroid hormone levels 
were normal. The gland consisted of two lobes of equal size, and there were no signs of 
hypoplasia or goiter. The only dissimilarity between the mutant animals and the wild type were at 
a histological level. The follicular epithelium in EphA4-/- and EphA4EGFP/EGFP glands was often 
more flat and the cells displayed a very thin apical cytoplasm with elongated nuclei. 
Morphometric data over size and numbers of follicles showed that EphA4-/- thyroids contained a 
significantly higher number of small-sized follicles (<1000?m2) compared to EphA4EGFP/EGFP and 
wild-type mice. The oversized follicles (>3000?m2), that were in total in minority, were more 
frequent in EphA4EGFP/EGFP glands outnumbering even those in the wild-type. The number of 
follicles of intermediated size (1000-3000 ?m2) did not differ between genotypes.  Total follicular 
volume estimated from the surface area in serial sections did not significantly differ. In summary, 
the results demonstrate an altered follicular morphology in mice either lacking EphA4 or in 
which the forward intracellular signalling domain of the receptor is missing. This indicates that 
EphA4 regulates follicular cell behaviour cell-autonomously. 
When adult wild-type mice were given MMI and ClO4- in drinking water for two weeks the 
intrathyroidal iodine metabolism was blocked and the mice became hypothyroid and thereby the 
endogenous levels of TSH were increased (paper IV). The histology of the gland was 
fundamentally altered and solid tissues of hyperplastic epithelium replaced the majority of the 
follicles. This tissue remodelling due to hyperplasia was found to be much less prominent in 
EphA4 mutant mice, the difference was most evident in EphA4 deficient animals. Animals treated 
with MMI and ClO4- obtained increased angiogenesis, however EphA4 knockout mice that 
displayed less hyperplasia also exhibited a reduced amount of microvessels than equally treated 
wild-type mice. Hormonal analysis further suggested that the poor thyroid growth response to 
goitrogens in EphA4 mutant mice, which included also haploinsufficient animals, depends on a 
thyroid defect rather than a pituitary defect (paper IV). 
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In 1962, Copp et al discovered a cell that could produce calcitonin, they named it the C-cell 
(Copp, et al. 1962). It is generally agreed that C-cells are neuroectodermal emanating from the 
neural crest, ever since this was first shown in chick-quail chimera experiment (Polak et al. 
1974). Fate mapping studies of Wnt1 expressing neural crest progenitors in mice recently 
challenged this concept (Kameda et al. 2007). Specifically, Wnt1-Cre/Rosa26R double 
heterozygous mutant embryos mapped neural crest-derived cells known to populate the 
pharyngeal arches but failed to identify any Wnt1 expressing cells in the ultimobranchial bodies 
or in thyroid co-localizing with the C-cells. Moreover, the C-cells were found to express the 
epithelial marker, E-cadherin. From this, the authors postulated that C-cells might derive from the 
endoderm rather than the neuroectoderm. The C-cells origin in higher vertebrates is therefore a 
controversy. In paper II, we used Tbx1 as a marker of foregut endoderm that is absent in neural 
crest cells. In recent studies (Fagman et al. 2007), investigation of the midline thyroid primodium 
revealed no Tbx1 expression at all in the placode; Tbx1 would therefore also probably 
discriminate between different thyroid progenitors. Double heterozygous Tbx1-CreRosa26R 
offsprings was used to trace descending progenitors. Tbx1 expression detected by X-gal staining 
could be found in the developing thyroid. As assumed, there were no ?-gal activity detected in 
the thyroid follicular cells. The cells that were expressing Tbx1-Cre were mainly located centrally 
in the lobes and some of them were co-expressing calcitonin. Based on the Tbx1 results, we 
further investigated in paper II whether members of the Foxa family of forkhead transcription 
factors known to be expressed in all the endoderm, but excluded from neural crest, could be used 
to label thyroid progenitor cells and further give strength to the endoderm origin hypothesis of 
mouse C-cells. 
Godt{qpke"fgxgnqrogpv"
The lateral thyroid primordia, the paired ultimobranchial bodies, develop from the fourth 
pharyngeal pouches and transport C-cell precursors to the thyroid. In paper II 
immunohistochemical staining revealed that the budding ultimobranchial bodies were mostly 
Foxa2 negative, whereas the adjacent endoderm surrounding the pharynx uniformly expressed 
Foxa2. At the base of the ultimobranchial bud, there was a clear separation between Foxa2 
positive and Foxa2 negative epithelium. Foxa2 was increasingly up-regulated in the 
ultimobranchial bodies between E11.5-13.5 and most cells were expressing Foxa2 immediately 
before fusion with the midline thyroid, which was still entirely Foxa2 negative.  
The ultimobranchial epithelium also gradually acquired Nkx2.1 expression, which in fact 
preceded the expression of Foxa2 in the same cells. After fusion could cells of the former 
ultimobranchial bodies be distinguished from the thyroid primodium cells by a weaker Nkx2.1 
expression as well as lack of BrdU labelling and Pax8 negativity. This suggested that the growth 
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properties of the ultimobranchial bodies changed after fusion with the midline thyroid anlage 
(paper I). Until the fusion stage, the ultimobranchial bodies uniformly expressed EphA4 (EGFP-
tagged). However, as ultimobranchial bodies approached the median anlage the EGFP expression 
signal became weaker and eventually undetectable at E13.5. In contrast, EphA4-EGFP was 
strongly expressed in progenitors of the former median thyroid including those cells that where in 
immediate contact with the UB border (paper III). Possibly, down-regulation of EphA4 in the 
ultimobranchial bodies is critical for fusion process and delivery of C-cell precursors to the 
thyroid. 
As the developing thyroid lobes enlarge the C-cells increase in number and start to produce 
calcitonin around embryonic day 15 (paper I). Immunolabeling for calcitonin showed that the 
differentiated C-cells were all EphA4-EGFP negative. The number of C-cells present in the 
thyroid in late development (E17.5) did not differ between wild-type and EphA4 mutant embryos, 
indicating that EphA4 is not required for the propagation of the C-cell lineage in fetal life (paper 
III). Foxa1 and Foxa2 were co-expressed in the central portions of the parenchyma at E13.5. 
Immunolabeling showed that Foxa2 (and Foxa1) and calcitonin were co-expressed in embryonic 
C-cells, although Foxa2 positive cells were more numerous presumably representing immature 
yet undifferentiated C-cell precursors. These observations provide evidence for that mouse C-
cells and the ultimobranchial epithelium share the same endoderm markers, indicating that C-cell 
precursors most likely derive from the foregut endoderm (paper II). 
Rquv/pcvcn"fgxgnqrogpv"
In paper III we have revealed that EphA4EGFP/EGFP (11020+/-827 (n = 4)) have significantly 
reduced numbers of C-cells immunoreactive for calcitonin whereas there were no differences 
between wild-type (26026+/-1670 (n = 6)); and EphA4-/- (27590+/-6000 (n = 4)) mice. The 
number of C-cells were 58% higher in normal animals than in the thyroid of EphA4-EGFP 
homozygous mice.  In late development (E17.5) the amount of C-cells present in the thyroid were 
equal comparing wild-type and EphA4 mutant embryos.  As EphA4 expression was restricted to 
the follicular epithelium, these observations indicate that EphA4 in thyrocytes cell-non-
automously regulates the proliferation of the C-cell after birth and possibly also in the adult 
gland. An explanation to this may be offered by previously published data on the same mutant 
mice by Dufour, et al, who discovered that the most sever phenotype in the somatosensory 
system accounts for homozygous EphA4-EFGP mice and not, as one might first assume, EphA4 
null animals (Dufour et al. 2006). It is suggested that EphA4-EGFP is unable to interact with 
other Eph receptors on the same cell (by cis-interactions) and that this in turn exerts a dominate 
negative effect.  
Lastly, evaluation of a microarray tumor data bank revelaed that Foxa2 is expressed in medullary 
thyroid carcinoma (MTC) but not in cancer derived from the follicular epithelium. This suggests 
that Foxa2 might be a novel biomarker of MTC (paper II).  
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 E9.5 E10.5 E11.5 E12.5 E13.5 E15.5 E17.5 
EphA4 Th + + + + + + + 
EphA4 
UB 
  + + - - - 
Foxa2 Th - (+) - - - - - - 
Foxa2 UB  -(+) + + + + + 
Foxa1 Th        
Foxa1 UB   + + + + + 
Table 1 .  Summary over EphA4, Foxa2, Foxa1 expression in thyroid midline anlage (Th) and 
ultimobranchial body (UB) during the different developmental stages. High expression is marked with a +, 
low –(+), undetectable expressions is marked with -.  Empty cells is not experimentally studied. 
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OCLQT"EQPENWUKQPU"QH"VJG"VJGUKU"RCRGTU"
Paper I: 
•" The midline thyroid develops in close proximity to embryonic vessels suggesting these 
participate as guiding tracks for thyroid organogenesis. 
 
•" Progenitor cell proliferation of the follicular lineage is a late event, suggesting that 
expansion of the specified precursor pool forming the bud occurs by recruitment of cells 
from other parts of the foregut endoderm. 
 
Paper II: 
•" Mouse C-cell precursors in the pharyngeal endoderm express Tbx1 and Foxa1/2, arguing 
against a neural crest origin of C-cells in higher vertebrates. 
 
•" Foxa2 is a novel marker of medullary thyroid carcinoma in humans. 
 
Paper III: 
•" The Eph receptor EphA4 is expressed in thyroid progenitors in early development and in 
differentiated follicular cells in late development. 
 
•" Follicular structure and number of differentiated thyroid C-cells are modulated by EphA4 
post-natally. 
 
Paper IV: 
•" Thyroid growth response to goitrogenic stimulation requires EphA4 presumably by a cell-
autonomous mode of action in the follicular cells. 
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CEMPQYNGFIGOGPVU"?"VCEM#"
Resan hit har varit lång och händelserik, tack alla ni som gjort min resa till ett fantastiskt äventyr 
och som stöttat och trott på mig! 
Den första att tacka är förstås min handledare Mikael Nilsson. Tack för att du tog hand om mig 
och mina EphA4 möss när vi var vilsna. Du har verkligen varit en fantastisk handledare och jag 
har alltid känt att du har haft tid för mig när jag behövt det. Tack också för att du är en så otroligt 
snäll person. Din forskarglädje och entusiasm har hjälp mig i så väl med som motgångar. 
Henrik Fagman, min bihandledare, för att jag fick ta vid där du slutade. Du har en otrolig 
kunskap som du är fantastiskt duktig på att dela med dig av. Tack för att du alltid ger mig svar på 
mina frågor.  
Jessica Westerlund, min kollega, båskompis, och vän! Tack för att du introducerade mig till 
thyroideans värld. Tack också för att du delat så väl med som motgångar med mig samt för alla 
timmar framför micket och i djurhuset. Saknar dig oerhört mycket, Holland är ibland ett land 
väldigt långt bort. 
Therese Carlsson, världens bästa forskningslaborant!  Tack för att du har koll på allt och alla. 
Utan dig hade jag inte hunnit köra alla immunofärgningar och inte heller vetat att det finns jeans 
som kostar 5000:-.  
Camilla Ingeson, min båsgranne och den person som likt mig är en forsknings-bergochdalbane-
åkare som blandar höga toppar med djupa dalar ?. Är jätteglad att du började i vår grupp, du har 
en fantastisk energi och glädje som du sprider omkring dig. Tack också för att du hållit mig 
uppdaterad när det gäller fotboll och div. andra sporter. 
Shawn Liang, den nyaste medlemmen i gruppen. Tack för all hjälp med korrekturläsningen, samt 
för att du är en härlig person med stort intresse för forskning.  
Madeleine Nordén Lyckesvärd, f.d. båsgranne och vän, tack för att jag fått dela så väl 
forskningserfarenheter som mamma-tips med dig. Du är en härlig tjej och ett riktigt energiknippe. 
Lars E Eriksson, för att du vet allt om allt och aldrig tackar nej till en diskussion, oavsett om det 
gäller kungahuset eller forskningen. Tack för att du är en omtänksam person. 
Fredrik Larsson, Sofia Tedelind, Nirmal Bohgal, Daniel Löfgren, forna medlemmar av 
gruppen, saknar er alla. Tack för att ni gjorde så jag direkt kände mig välkommen till gruppen. 
Tack också till alla medförfattare till arbetena i avhandlingen. 
 
Tack till kolleger och vänner: 
Erika, min kollega och fantastiska vän. Tack för alla underbara stunder både tillsammans med 
familjerna och på tur man hand. Du har gett mig så otroligt mycket både när det gäller forskning 
och vänskap och att du har stöttat och peppat mig i alla lägen. Jag tycker så mycket om dig och 
din härliga familj; Jonas, Viggo och lilla Alva (som vi längtar efter att få lära känna och se vad du 
är för en underbar liten person). Tack Erika för att du är en så färgstark person med en otrolig inre 
kraft och styrka. Hoppas på många härliga stunder framöver tillsammans med er! 
44
LOUISE ANDERSSON 
45 
 
 
Tack, Anna Nilton för forskarglädje och roliga stunder tillsammans, Yalda Rahpeymai 
Bogestål för att du en så entusiastisk och härlig person, tack också för hjälp med planeringen 
inför festen. Anne Uv och Stina Simonsson för att ni är inspirerande forskare som visar att 
kvinnor kan! Paula Morelli, för alla härliga te-pauser med mycket skratt och 
mammaerfarenheter. Tack för att vi fick komma och hälsa på dig och din familj i Skottland! 
Simin Rymo, härligt att ha dig tillbaks i Götet. Tack för att du är en så snäll och omtänksam 
person. Lycka till med avhandlingen! Elisabet Carlsohn, för att du delade engelskalektionerna 
med mig samt att du är en inspirerande tjej med mycket energi och glädje. Tack Helena 
Johansson och Dzeneta Vizlin Hodzic för att ni livar upp suterrängvåningen och alltid är härligt 
positiva och hjälpsamma . Lycka till med era avhandlingar! Tina Chavoshi, för trevligt sällskap 
på ”studentlab” samt för att du är en härligt glad och go tjej. Du kommer bli den bästa av 
mammor! Cecilia Bondjers och Alexandra Abramsson, för mysiga fikor och luncher under 
”Medkem”tiden. Tack också för att ni introducerade mig för klättringen på ”fikahyllan” i Aspen. 
Fredrik Wolfhhagen, för mysiga morgonfikor och för att du är en härlig kille som är lätt att 
snacka med, saknar dig här i norr. Kornelia Krumkühler, för att du gjorde min första tid på 
Medkem till en fantastiskt härlig period. Du är en färgstark person som sprider mycket positiv 
energi omkring dig! 
Tack till Jan-Olof Karlsson, Madeleine Zetterberg, Dragana Celojevic, Anne Petersen, för 
tidigt morgon sällskap och roliga luncher med mycket skratt. Tack för att ni har gett min insikt 
om kattavel och PT ;-). 
Tack alla i elektronmikroskopi-gänget, Ulf Nannemark, Yvonne Josefsson för fantastisk hjälp 
med snittning och kul samtal, Kanita Cukur, för att du alltid är så glad och omtänksam, Bengt R 
Johansson, för hjälp med EM-mikroskopet och för att du är så kunnig och inspirerande. 
Tack Susann Teneberg med grupp för trevliga luncher och underhållande samtal under min tid 
på ”Medkem”. 
Tack alla i Gunnar Hanssons, Milos och Marcelas grupp för att ni håller oss sällskap nere i 
källaren. 
Tack alla i Sven Enebäcks grupp, speciellt Zara Arani för trevliga pratstunder, tack för att din 
oerhörda omtanke, samt Daniel Nilsson och Mikael Hegelind för tips och hjälp med b.la. 
kloningen samt kul undervisningssällskap under studentlaborationerna. 
Tack till Julia Fernandez-Rodrigues och Maria Smed  på CCI, för att ni är så kunniga och 
hjälpsamma med konfokalmikroskopet. 
Tack alla ATCGare ute på AstraZeneca, det var en underbar period i mitt liv som gav mig 
otroligt mycket kunskap. Saknar er alla och även den underbara restaurangen ?. 
Klas Kullander, för att jag fick börja min doktorandtid hos dig, samt för EphA4 mössen. 
Tusen tack till alla på kansliet. Cecilia Koskinen, för trevliga samtal och delade barn-
erfarenheter, Carina Ejdeholm, Katarina Bergholtz, Chatrine Butler och Ulrica Lilja, för att 
alla hjälp med det administrativa speciellt när det krånglat till sig. 
Tack alla ni som håller det rent och fint hos oss. 
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Tack alla djurskötare, för omsorg om mössen. 
 
Och så alla utanför labbet… 
Therése, min själsfrände och älskade vän. Tack för att du delar allt med mig. Du har betytt 
otroligt mycket för mig dom här åren och jag hoppas på att få dela resten av mitt liv med dig ?. 
Tack också till fantastiske Hans som gör min bästaste vän lycklig varje dag, du är en härlig och 
omtänksam person. Enligt Rasmus är du den starkaste vi känner, vilket är ett ganska högt betyg 
från en fyraåring! 
Boklubbstjejerna: Fantastiskt att vi snart hållit igång bokklubben i 4.5år trots stor tillökning av 
barn?. Längtar tills vi kör igång på riktigt igen. Tack för fantastiskt god mat och inspirerande 
läsning, det är härligt att få träffas en gång i månaden, skratta ihop och uppdatera varandra.  
Jenny, tack för att du är en så fin och oerhört omtänksam person. Tack för att du kan dela dåligt 
lokalsinne, föräldraskapstänk, samt har kunskap om hur man tänker med magen. Sanna, för att 
du är en härlig person med lätt till skratt som alltid tänker på oss andra. Tänk att vi snart känt 
varandra halva livet… Hoppas på många fler härliga bokklubbskvällar! Tack också till Johan, 
Arvid och Lovisa (den lilla Valborgstjejen som vi längtar efter att få lära känna och se vad du är 
för en underbar liten person), Matts och Pelle. Speciellt tack för att jag en gång i månaden får 
låna Sanna och Jenny! Tack Sara för att du är en så glad och go tjej, saknar dig här nere i Götet. 
Lina och David för att ni är bland dom snällaste personerna jag känner. Tack för delade 
semestrar och härliga middagar, och för att ni vet vad riktig hungerma innebär. Tack också för att 
ni är så otroligt fina mot Rasmus och Hugo. Ni kommer bli de bästa föräldrar!! 
Jesper, Tobias, Björn, Lasse, för härliga fester och skön skidåkning. Kommer aldrig glömma 
Moena… Ulrika, Elisabeth och Sara för att ni är dom bästa tjejerna man kan önska sina 
killkompisar. 
Henrik och Gerd, för mysiga fikor och lekstunder. Tack för att ni är så härliga att umgås med. 
Tack också för att ni så ofta tar er tid att besöka oss när ni är ”hemma”, betyder jättemycket för 
mig. 
Lisa och Daniel, för många långa år tillsammans. För att gammal vänskap bara blir starkare med 
åren. Tack för ni alltid finns där för oss även om det ibland går lång tid emellan gångerna vi ses. 
Tor, för all hjälp med både huset och barnen. Tack för att du alltid ställer upp och är en så 
otroligt snäll person. Barnens bästa legobyggar-kompis! 
Ingrid och Oscar, tack för att ni alltid känns nära även om ni ibland till och med är på andra 
sidan jorden. Ni är härliga vänner som betyder mycket för oss. Just nu står Oscar högt upp på 
Hugos och Rasmus rankningslista, då han ju är ”riktig brandman” ?. 
Marco och Camilla, för fantastiska fotografiska insatser och roliga fester. Vi ser fram emot 
lekstunder tillsammans med barnen. 
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Josefina och Josef, tack för att ni förgyller alla släktmiddagar med er entusiasm och aldrig 
sinande leklust. Tack också för alla timmar på golvet tillsammans med killarna, betyder mycket ! 
Ni är så himla fina! 
Min lillebror Peter och hans fina familj: Madelen, Midas och Milly. Tack Peter för att du är du. 
Det var en härlig tid att växa upp tillsammans med dig! Tack också för att ni gett Rasmus och 
Hugo dom finaste små kusiner.  
Farmor Kerstin och farfar Kurt, tack för alla underbara somrar som ni gett mig och min familj 
ute på Hynnö! Bättre köp kunde ni inte gjort! Tack också för att ni alltid uppmuntrat och trott på 
mig. Tack för alla underbara kalas med otroligt god mat, tårtor och kakor ?. Ni kommer alltid 
finnas i mitt hjärta. 
Marta och Gunnar, för att ni alltid är så gästvänliga och att man alltid kan komma på 
oannonserat besök. Tack för fina kalas och goda middagar. 
Signe, för att du lärt mig elda och äta rejält med potatis. Samt för att man alltid har kunnat 
komma in till dig på en macka och te.  
Lisbeth och Mats, mina svärföräldrar. Tack för att ni alltid finns där för oss när vi behöver. Ni 
har hjälpt oss otroligt mycket med både huset och barnen. Tack för att ni alltid ser positivt på 
saker och ting och finner lösningar på problem. Tack för att ni är den bästa farmor och farfar! 
Mamma och pappa för att ni är dom bästa föräldrar man kan tänka sig. Tack för att ni alltid trott 
på mig och gett mig självförtroendet till att våga göra allt jag har velat. Tack också för all hjälp 
med barnen (bättre mormor och morfar kan man inte ha), huset och allt annat mellan himmel och 
jord. Tack för underbara semestrar både på skidor och till havs. 
Min man, livskamrat, bästa vän, och älskade, Teodor! Tack för att du aldrig slutat tro på mig och 
för all fantastisk stöttning den här tiden. Du är en underbart omtänksam man med otrolig energi 
och livsglädje. Tack för att du låtit mig utbilda mig till både Doula och Profylaxinstruktör samt 
stått pall under alla doktorand åren. Du är den finaste pappan man kan tänka sig och den mest 
underbara man. Har snart delat halva mitt liv med dig och älskar dig mer för varje dag. Du och 
jag för alltid, för evigt det vore väl trevligt. 
Rasmus och Hugo för att ni är så otroligt fina. Det är en helt fantastisk känsla att komma hem 
efter jobbet och bli mött av era varma kramar och glada leenden. Älskar er mer än jag kan skriva i 
ord... 
 
Tack alla än en gång! 
" "
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